{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:35:13Z","timestamp":1760488513684,"version":"build-2065373602"},"reference-count":375,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03999-1","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:15:29Z","timestamp":1760451329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The multiplex crosstalk between non-coding RNAs, programmed cell death and related mechanisms: a dynamic duo in hematological malignancies"],"prefix":"10.1186","volume":"25","author":[{"given":"Mehrdad","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Salimian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafiseh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pezhman","family":"Shafiei Asheghabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Zarearandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Abdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranaz","family":"SeyedAli Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza Mohajer","family":"Shirazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Bagheri Pozve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Nikdehqan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrandokht","family":"Nekavand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Khazaei Koohpar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najma","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobina","family":"Shariatzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Alimohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payman","family":"Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Taheriazam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"1","key":"3999_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao A, Zhou H, Yang J, Li M, Niu T. Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct Target Ther. 2023;8(1):71.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3999_CR2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1039\/D1CS00755F","volume":"51","author":"T Ci","year":"2022","unstructured":"Ci T, Zhang W, Qiao Y, Li H, Zang J, Li H, et al. Delivery strategies in treatments of leukemia. Chem Soc Rev. 2022;51(6):2121\u201344.","journal-title":"Chem Soc Rev"},{"issue":"2","key":"3999_CR3","first-page":"e528","volume":"5","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, Mateos M-V, Zweegman S, Cook G, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Hemasphere. 2021;5(2):e528.","journal-title":"Hemasphere"},{"issue":"5","key":"3999_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma: a review. JAMA. 2022;327(5):464\u201377.","journal-title":"JAMA"},{"issue":"10091","key":"3999_CR5","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-hodgkin lymphoma. Lancet. 2017;390(10091):298\u2013310.","journal-title":"Lancet"},{"issue":"7","key":"3999_CR6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720\u201348.","journal-title":"Leukemia"},{"issue":"5","key":"3999_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2023.5509","volume":"62","author":"Y Che","year":"2023","unstructured":"Che Y, Ding X, Xu L, Zhao J, Zhang X, Li N, et al. Advances in the treatment of Hodgkin\u2019s lymphoma. Int J Oncol. 2023;62(5):1\u201314.","journal-title":"Int J Oncol"},{"key":"3999_CR8","doi-asserted-by":"crossref","unstructured":"Ansell SM, editor. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clinic Proceedings; 2015: Elsevier.","DOI":"10.1016\/j.mayocp.2015.04.025"},{"issue":"1","key":"3999_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01521-5","volume":"8","author":"L Tang","year":"2023","unstructured":"Tang L, Huang Z, Mei H, Hu Y. Immunotherapy in hematologic malignancies: achievements, challenges and future prospects. Signal Transduct Target Ther. 2023;8(1):306.","journal-title":"Signal Transduct Target Ther"},{"key":"3999_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1284934","volume":"12","author":"Z Han","year":"2024","unstructured":"Han Z, Luo W, Shen J, Xie F, Luo J, Yang X, et al. Non-coding RNAs are involved in tumor cell death and affect tumorigenesis, progression, and treatment: a systematic review. Front Cell Dev Biol. 2024;12:1284934.","journal-title":"Front Cell Dev Biol"},{"key":"3999_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172976","volume":"875","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Esmaeili M, Taheri M. Expression of non-coding RNAs in hematological malignancies. Eur J Pharmacol. 2020;875:172976.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"3999_CR12","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","volume":"55","author":"E Lee","year":"2023","unstructured":"Lee E, Song C-H, Bae S-J, Ha K-T, Karki R. Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis. Exp Mol Med. 2023;55(8):1632\u201343.","journal-title":"Exp Mol Med"},{"issue":"3","key":"3999_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3999_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng F, Liao M, Qin R, Zhu S, Peng C, Fu L, et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal Transduct Target Ther. 2022;7(1):286.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3999_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/cdd.2014.137","volume":"22","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Pedro B-S, Vitale I, Aaronson S, Abrams J, Adam D, et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 2015;22(1):58\u201373.","journal-title":"Cell Death Differ"},{"issue":"2","key":"3999_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.drudis.2021.10.011","volume":"27","author":"W Liu","year":"2022","unstructured":"Liu W, Jin W, Zhu S, Chen Y, Liu B. Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: a revisited review of apoptosis, autophagy-dependent cell death and necroptosis. Drug Discov Today. 2022;27(2):612\u201325.","journal-title":"Drug Discov Today"},{"issue":"8","key":"3999_CR17","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395.","journal-title":"Autophagy"},{"issue":"9","key":"3999_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov. 2023;22(9):723\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"3999_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2023.10.001","author":"A Pandeya","year":"2024","unstructured":"Pandeya A, Kanneganti T-D. Therapeutic potential of panoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes. Trends Mol Med. 2024;30(1):74\u201388. https:\/\/doi.org\/10.1016\/j.molmed.2023.10.001","journal-title":"Trends Mol Med"},{"issue":"4","key":"3999_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","volume":"3","author":"A Najafov","year":"2017","unstructured":"Najafov A, Chen H, Yuan J. Necroptosis and cancer. Trends Cancer. 2017;3(4):294\u2013301.","journal-title":"Trends Cancer"},{"issue":"8","key":"3999_CR21","doi-asserted-by":"publisher","first-page":"e1384","DOI":"10.1038\/cddis.2014.347","volume":"5","author":"A-L Nugues","year":"2014","unstructured":"Nugues A-L, El Bouazzati H, Hetuin D, Berthon C, Loyens A, Bertrand E, et al. RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65\/RelA cleavage. Cell Death Dis. 2014;5(8):e1384\u2013e.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3999_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","volume":"30","author":"U H\u00f6ckendorf","year":"2016","unstructured":"H\u00f6ckendorf U, Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, et al. RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells. Cancer Cell. 2016;30(1):75\u201391.","journal-title":"Cancer Cell"},{"issue":"13","key":"3999_CR23","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1182\/blood.2020006785","volume":"138","author":"AW Roberts","year":"2021","unstructured":"Roberts AW, Wei AH, Huang DC. BCL2 and MCL1 inhibitors for hematologic malignancies. Blood. 2021;138(13):1120\u201336.","journal-title":"Blood"},{"issue":"39","key":"3999_CR24","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102(39):13944\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3999_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/s41375-019-0623-5","volume":"34","author":"G Montalban-Bravo","year":"2020","unstructured":"Montalban-Bravo G, Class CA, Ganan-Gomez I, Kanagal-Shamanna R, Sasaki K, Richard-Carpentier G, et al. Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes. Leukemia. 2020;34(3):872\u201381.","journal-title":"Leukemia"},{"key":"3999_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"AA Bhat","year":"2020","unstructured":"Bhat AA, Younes SN, Raza SS, Zarif L, Nisar S, Ahmed I, et al. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance. Mol Cancer. 2020;19:1\u201321.","journal-title":"Mol Cancer"},{"issue":"5","key":"3999_CR27","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00277-023-05383-3","volume":"103","author":"A Rahmati","year":"2024","unstructured":"Rahmati A, Mafi A, Vakili O, Soleymani F, Alishahi Z, Yahyazadeh S, et al. Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways. Ann Hematol. 2024;103(5):1455\u201382.","journal-title":"Ann Hematol"},{"issue":"3","key":"3999_CR28","first-page":"1406","volume":"14","author":"M Bhattacharya","year":"2022","unstructured":"Bhattacharya M, Gutti RK. Non-coding RNAs: are they the protagonist or antagonist in the regulation of leukemia? Am J Transl Res. 2022;14(3):1406.","journal-title":"Am J Transl Res"},{"issue":"1","key":"3999_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-021-00596-9","volume":"7","author":"Y Liu","year":"2021","unstructured":"Liu Y, Chen Q, Zhu Y, Wang T, Ye L, Han L, et al. Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis. Cell Death Discov. 2021;7(1):210.","journal-title":"Cell Death Discov"},{"key":"3999_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-018-0673-6","volume":"11","author":"NK Wong","year":"2018","unstructured":"Wong NK, Huang C-L, Islam R, Yip SP. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies. J Hematol Oncol. 2018;11:1\u201322.","journal-title":"J Hematol Oncol"},{"key":"3999_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1415801","volume":"14","author":"T Mohammad","year":"2024","unstructured":"Mohammad T, Zolotovskaia MA, Suntsova MV, Buzdin AA. Cancer fusion transcripts with human non-coding RNAs. Front Oncol. 2024;14:1415801.","journal-title":"Front Oncol"},{"issue":"12","key":"3999_CR32","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1182\/blood-2018-02-791350","volume":"132","author":"R Valentin","year":"2018","unstructured":"Valentin R, Grabow S, Davids MS. The rise of apoptosis: targeting apoptosis in hematologic malignancies. Blood. 2018;132(12):1248\u201364.","journal-title":"Blood"},{"issue":"2","key":"3999_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrc.2015.17","volume":"16","author":"AR Delbridge","year":"2016","unstructured":"Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies. Nat Rev Cancer. 2016;16(2):99\u2013109.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3999_CR34","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"12","key":"3999_CR35","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3324\/haematol.2008.001495","volume":"93","author":"G Ott","year":"2008","unstructured":"Ott G, Rosenwald A. Molecular pathogenesis of follicular lymphoma. Haematologica. 2008;93(12):1773\u20136.","journal-title":"Haematologica"},{"issue":"14","key":"3999_CR36","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1182\/blood-2010-11-317438","volume":"118","author":"L Bodet","year":"2011","unstructured":"Bodet L, Gomez-Bougie P, Touzeau C, Dousset C, Descamps G, Ma\u00efga S, et al. ABT-737 is highly effective against molecular subgroups of multiple myeloma. Blood. 2011;118(14):3901\u201310.","journal-title":"Blood"},{"issue":"3","key":"3999_CR37","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1182\/blood.V90.3.1168","volume":"90","author":"O Monni","year":"1997","unstructured":"Monni O, Joensuu H, Franssila K, Klefstrom J, Alitalo K, Knuutila S. Bcl2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood. 1997;90(3):1168\u201374.","journal-title":"Blood"},{"issue":"8","key":"3999_CR38","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/leu.2015.99","volume":"29","author":"L Li","year":"2015","unstructured":"Li L, Pongtornpipat P, Tiutan T, Kendrick SL, Park S, Persky DO, et al. Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1. Leukemia. 2015;29(8):1702\u201312.","journal-title":"Leukemia"},{"issue":"6","key":"3999_CR39","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/leu.2012.367","volume":"27","author":"S Wenzel","year":"2013","unstructured":"Wenzel S, Grau M, Mavis C, Hailfinger S, Wolf A, Madle H, et al. MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma. Leukemia. 2013;27(6):1381\u201390.","journal-title":"Leukemia"},{"issue":"6","key":"3999_CR40","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason KD, Carpinelli MR, Fletcher JI, Collinge JE, Hilton AA, Ellis S, et al. Programmed anuclear cell death delimits platelet life span. Cell. 2007;128(6):1173\u201386.","journal-title":"Cell"},{"issue":"9","key":"3999_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJM199802263380902","volume":"338","author":"M Silva","year":"1998","unstructured":"Silva M, Richard C, Benito A, Sanz C, Olalla I, Fern\u00e1ndez-Luna JL. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med. 1998;338(9):564\u201371.","journal-title":"N Engl J Med"},{"issue":"10","key":"3999_CR42","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/biom10101431","volume":"10","author":"A Negroni","year":"2020","unstructured":"Negroni A, Colantoni E, Cucchiara S, Stronati L. Necroptosis in intestinal inflammation and cancer: new concepts and therapeutic perspectives. Biomolecules. 2020;10(10):1431.","journal-title":"Biomolecules"},{"issue":"7534","key":"3999_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature14191","volume":"517","author":"M Pasparakis","year":"2015","unstructured":"Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nature. 2015;517(7534):311\u201320.","journal-title":"Nature"},{"issue":"14","key":"3999_CR44","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci U S A. 2012;109(14):5322\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7778","key":"3999_CR45","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","volume":"574","author":"K Newton","year":"2019","unstructured":"Newton K, Wickliffe KE, Dugger DL, Maltzman A, Roose-Girma M, Dohse M, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature. 2019;574(7778):428\u201331.","journal-title":"Nature"},{"issue":"26","key":"3999_CR46","doi-asserted-by":"publisher","first-page":"E5944","DOI":"10.1073\/pnas.1806973115","volume":"115","author":"P Amin","year":"2018","unstructured":"Amin P, Florez M, Najafov A, Pan H, Geng J, Ofengeim D, et al. Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNF\u03b1-mediated apoptosis. Proc Natl Acad Sci U S A. 2018;115(26):E5944-53.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3999_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/nrm.2016.149","volume":"18","author":"R Weinlich","year":"2017","unstructured":"Weinlich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol. 2017;18(2):127\u201336.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3999_CR48","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2012","unstructured":"Upton JW, Kaiser WJ, Mocarski ES. DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2012;11(3):290\u20137.","journal-title":"Cell Host Microbe"},{"issue":"43","key":"3999_CR49","doi-asserted-by":"publisher","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","volume":"288","author":"WJ Kaiser","year":"2013","unstructured":"Kaiser WJ, Sridharan H, Huang C, Mandal P, Upton JW, Gough PJ, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL. J Biol Chem. 2013;288(43):31268\u201379.","journal-title":"J Biol Chem"},{"issue":"8","key":"3999_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005756","volume":"16","author":"A Najafov","year":"2018","unstructured":"Najafov A, Zervantonakis IK, Mookhtiar AK, Greninger P, March RJ, Egan RK, et al. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol. 2018;16(8):e2005756.","journal-title":"PLoS Biol"},{"issue":"8","key":"3999_CR51","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1038\/s41418-020-0576-2","volume":"27","author":"R Thijssen","year":"2020","unstructured":"Thijssen R, Alvarez-Diaz S, Grace C, Gao M-y, Segal DH, Xu Z, et al. Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells. Cell Death Differ. 2020;27(8):2531\u20133.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3999_CR52","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev-biochem-060815-014830","volume":"85","author":"K Newton","year":"2016","unstructured":"Newton K, Manning G. Necroptosis and inflammation. Annu Rev Biochem. 2016;85(1):743\u201363.","journal-title":"Annu Rev Biochem"},{"key":"3999_CR53","doi-asserted-by":"publisher","first-page":"1114103","DOI":"10.3389\/fimmu.2023.1114103","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Tang A-L, Chen J, Gao N, Zhang G, Xiao C. RIPK1 in the inflammatory response and sepsis: recent advances, drug discovery and beyond. Front Immunol. 2023;14:1114103.","journal-title":"Front Immunol"},{"issue":"6","key":"3999_CR54","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1002\/ijc.32246","volume":"145","author":"LK Hillert","year":"2019","unstructured":"Hillert LK, Bettermann-Bethge K, Nimmagadda SC, Fischer T, Naumann M, Lavrik IN. Targeting RIPK1 in AML cells carrying FLT3\u2010ITD. Int J Cancer. 2019;145(6):1558\u201369.","journal-title":"Int J Cancer"},{"issue":"5","key":"3999_CR55","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/10428194.2021.2010056","volume":"63","author":"J Li","year":"2022","unstructured":"Li J, Liao D, Wang F, Wang Z, Li Y, Xiong Y, et al. RIPK1 inhibition enhances the therapeutic efficacy of Chidamide in FLT3-ITD positive AML, both in vitro and in vivo. Leuk Lymphoma. 2022;63(5):1167\u201379.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3999_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00725-z","volume":"14","author":"B Wu","year":"2023","unstructured":"Wu B, Li J, Wang H, Liu J, Li J, Sun F, et al. RIPK1 is aberrantly expressed in multiple B-cell cancers and implicated in the underlying pathogenesis. Discover Oncol. 2023;14(1):131.","journal-title":"Discover Oncol"},{"issue":"2","key":"3999_CR57","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrmicro2070","volume":"7","author":"T Bergsbaken","year":"2009","unstructured":"Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99\u2013109.","journal-title":"Nat Rev Microbiol"},{"key":"3999_CR58","doi-asserted-by":"publisher","first-page":"1290885","DOI":"10.3389\/fimmu.2023.1290885","volume":"14","author":"H-m You","year":"2023","unstructured":"You H-m, Wang L, Meng H-w, Huang C, Fang G-y, Li J. Pyroptosis: shedding light on the mechanisms and links with cancers. Front Immunol. 2023;14:1290885.","journal-title":"Front Immunol"},{"key":"3999_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1155222","volume":"14","author":"Y Tan","year":"2023","unstructured":"Tan Y, Liu Q, Li Z, Yang S, Cui L. Pyroptosis-triggered pathogenesis: new insights on antiphospholipid syndrome. Front Immunol. 2023;14:1155222.","journal-title":"Front Immunol"},{"issue":"4","key":"3999_CR60","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1002\/jcp.29268","volume":"235","author":"F Lu","year":"2020","unstructured":"Lu F, Lan Z, Xin Z, He C, Guo Z, Xia X, et al. Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases. J Cell Physiol. 2020;235(4):3207\u201321.","journal-title":"J Cell Physiol"},{"issue":"5","key":"3999_CR61","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/pro.2441","volume":"23","author":"B Krumm","year":"2014","unstructured":"Krumm B, Xiang Y, Deng J. Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses. Protein Sci. 2014;23(5):526\u201338.","journal-title":"Protein Sci"},{"issue":"5","key":"3999_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.intimp.2010.11.025","volume":"11","author":"M Chen","year":"2011","unstructured":"Chen M, Wang H, Chen W, Meng G. Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol. 2011;11(5):549\u201354.","journal-title":"Int Immunopharmacol"},{"key":"3999_CR63","doi-asserted-by":"crossref","unstructured":"Novick D, Kim S, Kaplanski G, Dinarello CA, editors. Interleukin-18, more than a Th1 cytokine. Seminars in immunology. Elsevier; 2013.","DOI":"10.1016\/j.smim.2013.10.014"},{"issue":"7610","key":"3999_CR64","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535(7610):153\u20138.","journal-title":"Nature"},{"issue":"7575","key":"3999_CR65","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666\u201371.","journal-title":"Nature"},{"issue":"46","key":"3999_CR66","doi-asserted-by":"publisher","first-page":"E10888","DOI":"10.1073\/pnas.1809548115","volume":"115","author":"J Sarhan","year":"2018","unstructured":"Sarhan J, Liu BC, Muendlein HI, Li P, Nilson R, Tang AY, et al. Caspase-8 induces cleavage of gasdermin D to elicit pyroptosis during Yersinia infection. Proc Natl Acad Sci U S A. 2018;115(46):E10888-97.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7661","key":"3999_CR67","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99\u2013103.","journal-title":"Nature"},{"issue":"6","key":"3999_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098899","volume":"9","author":"N Castano-Rodriguez","year":"2014","unstructured":"Castano-Rodriguez N, Kaakoush NO, Goh K-L, Fock KM, Mitchell HM. The NOD-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case-control study and gene expression analyses. PLoS ONE. 2014;9(6):e98899.","journal-title":"PLoS ONE"},{"issue":"11","key":"3999_CR69","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23973","volume":"35","author":"G Xu","year":"2021","unstructured":"Xu G, Huang R, Xia W, Jiang B, Xiao G, Li Y. Associations between inflammasome-related gene NLRP3 polymorphisms (rs10754558 and rs35829419) and risk of bladder cancer in a Chinese population. J Clin Lab Anal. 2021;35(11):e23973.","journal-title":"J Clin Lab Anal"},{"key":"3999_CR70","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S424326","author":"X Jing","year":"2023","unstructured":"Jing X, Yun Y, Ji X, Yang E, Li P. Pyroptosis and inflammasome-related genes-NLRP3, NLRC4 and NLRP7 polymorphisms were associated with risk of lung cancer. Pharmacogenomics Pers Med. 2023;16:795\u2013804. https:\/\/doi.org\/10.2147\/PGPM.S424326","journal-title":"Pharmacogenomics Pers Med"},{"key":"3999_CR71","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00005-015-0355-9","volume":"63","author":"A Miskiewicz","year":"2015","unstructured":"Miskiewicz A, Szparecki G, Durlik M, Rydzewska G, Ziobrowski I, G\u00f3rska R. The Q705K and F359L single-nucleotide polymorphisms of NOD-like receptor signaling pathway: association with chronic pancreatitis, pancreatic cancer, and periodontitis. Arch Immunol Ther Exp. 2015;63:485\u201394.","journal-title":"Arch Immunol Ther Exp"},{"issue":"1","key":"3999_CR72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-023-01407-7","volume":"16","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Li X, Wang Y, Wei Y, Wei X. Involvement of inflammasomes in tumor microenvironment and tumor therapies. J Hematol Oncol. 2023;16(1):24.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3999_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.humimm.2017.10.013","volume":"79","author":"A Zhang","year":"2018","unstructured":"Zhang A, Yu J, Yan S, Zhao X, Chen C, Zhou Y, et al. The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia. Hum Immunol. 2018;79(1):57\u201362.","journal-title":"Hum Immunol"},{"key":"3999_CR74","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S329090","author":"Z-H Liu","year":"2021","unstructured":"Liu Z-H, Zhang L, Jing F-J, Xiao S-X, Gao Y, Bian H-Y, et al. Genetic polymorphisms in NLRP3 inflammasome-associated genes in patients with B-cell non-Hodgkin\u2019s lymphoma. J Inflamm Res. 2021;14:5687\u201397. https:\/\/doi.org\/10.2147\/JIR.S329090","journal-title":"J Inflamm Res"},{"issue":"65","key":"3999_CR75","doi-asserted-by":"publisher","first-page":"108571","DOI":"10.18632\/oncotarget.21010","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao X, Zhang C, Hua M, Wang R, Zhong C, Yu J, et al. Nlrp3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma. Oncotarget. 2017;8(65):108571.","journal-title":"Oncotarget"},{"issue":"9","key":"3999_CR76","doi-asserted-by":"publisher","DOI":"10.2144\/fsoa-2019-0076","volume":"5","author":"HM Khaled","year":"2019","unstructured":"Khaled HM, Abdelhamid TM, Abu-Taleb FM, El-Hifnawi NM, Waley AB. Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimen. Future Sci OA. 2019;5(9):FSO414.","journal-title":"Future Sci OA"},{"issue":"2","key":"3999_CR77","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/10428194.2018.1480772","volume":"60","author":"SW Lim","year":"2019","unstructured":"Lim SW, Ryu KJ, Lee H, Ko YH, Kim WS, Kim SJ. Serum IL18 is associated with hemophagocytosis and poor survival in extranodal natural killer\/T-cell lymphoma. Leuk Lymphoma. 2019;60(2):317\u201325.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3999_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042369","volume":"25","author":"IE Stergiou","year":"2024","unstructured":"Stergiou IE, Tsironis C, Papadakos SP, Tsitsilonis OE, Dimopoulos MA, Theocharis S. Unraveling the role of the NLRP3 inflammasome in lymphoma: implications in pathogenesis and therapeutic strategies. Int J Mol Sci. 2024;25(4):2369.","journal-title":"Int J Mol Sci"},{"key":"3999_CR79","doi-asserted-by":"publisher","first-page":"1048567","DOI":"10.3389\/fimmu.2023.1048567","volume":"14","author":"L Serna","year":"2023","unstructured":"Serna L, Azcoaga P, Brahmachary M, Caffarel MM, Braza MS. Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature. Front Immunol. 2023;14:1048567.","journal-title":"Front Immunol"},{"key":"3999_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.779123","volume":"9","author":"W Wang","year":"2021","unstructured":"Wang W, Xu S-w, Teng Y, Zhu M, Guo Q-y, Wang Y-w, et al. The dark side of pyroptosis of diffuse large B-cell lymphoma in B-cell non-Hodgkin lymphoma: mediating the specific inflammatory microenvironment. Front Cell Dev Biol. 2021;9:779123.","journal-title":"Front Cell Dev Biol"},{"issue":"14","key":"3999_CR81","doi-asserted-by":"publisher","first-page":"12677","DOI":"10.1007\/s00432-023-05018-0","volume":"149","author":"L Lv","year":"2023","unstructured":"Lv L, Zhang Y, Kong R, Wang C, Wang X, Zhou X. Identification of pyroptosis-related signature and development of a novel prognostic model in diffuse large B-cell lymphoma. J Cancer Res Clin Oncol. 2023;149(14):12677\u201390.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3999_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175614","volume":"945","author":"X Yu","year":"2023","unstructured":"Yu X, Liu X, Liu X, Jin S, Zhong M, Nie D, et al. Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation. Eur J Pharmacol. 2023;945:175614.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"3999_CR83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.gendis.2019.06.002","volume":"6","author":"F Zhu","year":"2019","unstructured":"Zhu F, Rui L. PRMT5 in gene regulation and hematologic malignancies. Genes Dis. 2019;6(3):247\u201357.","journal-title":"Genes Dis"},{"issue":"7","key":"3999_CR84","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491\u2013502.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3999_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03035-2","volume":"11","author":"K-H Lim","year":"2020","unstructured":"Lim K-H, Chen L-C, Hsu K, Chang C-C, Chang C-Y, Kao C-W, et al. BAFF-driven NLRP3 inflammasome activation in B cells. Cell Death Dis. 2020;11(9):820.","journal-title":"Cell Death Dis"},{"issue":"5","key":"3999_CR86","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372.","journal-title":"Cell"},{"key":"3999_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115419","volume":"166","author":"S Hu","year":"2023","unstructured":"Hu S, Chu Y, Zhou X, Wang X. Recent advances of ferroptosis in tumor: from biological function to clinical application. Biomed Pharmacother. 2023;166:115419.","journal-title":"Biomed Pharmacother"},{"key":"3999_CR88","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"3999_CR89","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1):317\u201331.","journal-title":"Cell"},{"issue":"5","key":"3999_CR90","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41374-017-0008-1","volume":"98","author":"Y Kinowaki","year":"2018","unstructured":"Kinowaki Y, Kurata M, Ishibashi S, Ikeda M, Tatsuzawa A, Yamamoto M, et al. Glutathione peroxidase 4 overexpression inhibits ROS-induced cell death in diffuse large B-cell lymphoma. Lab Invest. 2018;98(5):609\u201319.","journal-title":"Lab Invest"},{"key":"3999_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118077","volume":"260","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Tian F, Ma H, Wang H, Yang W, Liu Z, et al. FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells. Life Sci. 2020;260:118077.","journal-title":"Life Sci"},{"issue":"6","key":"3999_CR92","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s10238-023-00996-4","volume":"23","author":"X Chen","year":"2023","unstructured":"Chen X, Hu S, Han Y, Cai Y, Lu T, Hu X, et al. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration. Clin Exp Med. 2023;23(6):2601\u201317.","journal-title":"Clin Exp Med"},{"key":"3999_CR93","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-3296","author":"J Wei","year":"2020","unstructured":"Wei J, Xie Q, Liu X, Wan C, Wu W, Fang K, et al. Identification the prognostic value of glutathione peroxidases expression levels in acute myeloid leukemia. Ann Transl Med. 2020. https:\/\/doi.org\/10.21037\/atm-20-3296.","journal-title":"Ann Transl Med"},{"key":"3999_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155811","author":"Z Dashti","year":"2024","unstructured":"Dashti Z, Yousefi Z, Kiani P, Taghizadeh M, Maleki MH, Borji M, et al. Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth. Metabolism. 2024;154:155811. https:\/\/doi.org\/10.1016\/j.metabol.2024.155811","journal-title":"Metabolism"},{"issue":"20","key":"3999_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205072","volume":"14","author":"O Garc\u00eda Ruiz","year":"2022","unstructured":"Garc\u00eda Ruiz O, S\u00e1nchez-Maldonado JM, L\u00f3pez-Nevot M\u00c1, Garc\u00eda P, Macauda A, Hern\u00e1ndez-Mohedo F, et al. Autophagy in hematological malignancies. Cancers (Basel). 2022;14(20):5072.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3999_CR96","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","volume":"40","author":"G Kroemer","year":"2010","unstructured":"Kroemer G, Mari\u00f1o G, Levine B. Autophagy and the integrated stress response. Mol Cell. 2010;40(2):280\u201393.","journal-title":"Mol Cell"},{"key":"3999_CR97","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drup.2014.12.001","volume":"18","author":"D Niewerth","year":"2015","unstructured":"Niewerth D, Jansen G, Assaraf YG, Zweegman S, Kaspers GJ, Cloos J. Molecular basis of resistance to proteasome inhibitors in hematological malignancies. Drug Resist Updat. 2015;18:18\u201335.","journal-title":"Drug Resist Updat"},{"key":"3999_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05207-0","author":"P Kiani","year":"2025","unstructured":"Kiani P, Khodadadi ES, Nikdasti A, Yarahmadi S, Gheibi M, Yousefi Z, et al. Autophagy and the peroxisome proliferator-activated receptor signaling pathway: a molecular ballet in lipid metabolism and homeostasis. Mol Cell Biochem. 2025;480(6):3477\u201399. https:\/\/doi.org\/10.1007\/s11010-025-05207-0","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3999_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01262-y","volume":"15","author":"W Seo","year":"2022","unstructured":"Seo W, Silwal P, Song I-C, Jo E-K. The dual role of autophagy in acute myeloid leukemia. J Hematol Oncol. 2022;15(1):51.","journal-title":"J Hematol Oncol"},{"issue":"10","key":"3999_CR100","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41375-018-0102-4","volume":"32","author":"S Rudat","year":"2018","unstructured":"Rudat S, Pfaus A, Cheng Y, Holtmann J, Ellegast JM, Buehler C, et al. RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia. Leukemia. 2018;32(10):2189\u2013202.","journal-title":"Leukemia"},{"issue":"7","key":"3999_CR101","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1182\/blood-2015-05-646497","volume":"127","author":"C Larrue","year":"2016","unstructured":"Larrue C, Saland E, Boutzen H, Vergez F, David M, Joffre C, et al. Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells. Blood. 2016;127(7):882\u201392.","journal-title":"Blood"},{"issue":"6","key":"3999_CR102","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/onc.2017.376","volume":"37","author":"Q Heydt","year":"2018","unstructured":"Heydt Q, Larrue C, Saland E, Bertoli S, Sarry J, Besson A, et al. Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia. Oncogene. 2018;37(6):787\u201397.","journal-title":"Oncogene"},{"issue":"8","key":"3999_CR103","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.7150\/thno.19439","volume":"7","author":"Q Zou","year":"2017","unstructured":"Zou Q, Tan S, Yang Z, Zhan Q, Jin H, Xian J, et al. NPM1 mutant mediated PML delocalization and stabilization enhances autophagy and cell survival in leukemic cells. Theranostics. 2017;7(8):2289.","journal-title":"Theranostics"},{"issue":"12","key":"3999_CR104","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2015-12-684696","volume":"128","author":"Y Sumitomo","year":"2016","unstructured":"Sumitomo Y, Koya J, Nakazaki K, Kataoka K, Tsuruta-Kishino T, Morita K, et al. Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 2016;128(12):1614\u201324.","journal-title":"Blood"},{"issue":"1","key":"3999_CR105","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/labmed\/lmaa027","volume":"52","author":"H Boustani","year":"2021","unstructured":"Boustani H, Khodadi E, Shahidi M. Autophagy in hematological malignancies: molecular aspects in leukemia and lymphoma. Lab Med. 2021;52(1):16\u201323.","journal-title":"Lab Med"},{"issue":"20","key":"3999_CR106","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1182\/blood-2016-10-745034","volume":"129","author":"N Man","year":"2017","unstructured":"Man N, Tan Y, Sun X-J, Liu F, Cheng G, Greenblatt SM, et al. Caspase-3 controls AML1-ETO\u2013driven leukemogenesis via autophagy modulation in a ULK1-dependent manner. Blood. 2017;129(20):2782\u201392.","journal-title":"Blood"},{"issue":"5","key":"3999_CR107","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/15548627.2017.1287652","volume":"13","author":"X Chen","year":"2017","unstructured":"Chen X, Clark J, Wunderlich M, Fan C, Davis A, Chen S, et al. Autophagy is dispensable for Kmt2a\/Mll-Mllt3\/Af9 AML maintenance and anti-leukemic effect of chloroquine. Autophagy. 2017;13(5):955\u201366.","journal-title":"Autophagy"},{"issue":"9","key":"3999_CR108","doi-asserted-by":"publisher","first-page":"e2361","DOI":"10.1038\/cddis.2016.264","volume":"7","author":"Q Liu","year":"2016","unstructured":"Liu Q, Chen L, Atkinson JM, Claxton DF, Wang H-G. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model. Cell Death Dis. 2016;7(9):e2361\u2013e.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3999_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05311-4","volume":"9","author":"I Piragyte","year":"2018","unstructured":"Piragyte I, Clapes T, Polyzou A, Klein Geltink RI, Lefkopoulos S, Yin N, et al. A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways. Nat Commun. 2018;9(1):3090.","journal-title":"Nat Commun"},{"issue":"10","key":"3999_CR110","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1080\/15548627.2015.1084454","volume":"11","author":"D Colecchia","year":"2015","unstructured":"Colecchia D, Rossi M, Sasdelli F, Sanzone S, Strambi A, Chiariello M. MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation. Autophagy. 2015;11(10):1790\u2013802.","journal-title":"Autophagy"},{"issue":"57","key":"3999_CR111","doi-asserted-by":"publisher","first-page":"96984","DOI":"10.18632\/oncotarget.18904","volume":"8","author":"A Ianniciello","year":"2017","unstructured":"Ianniciello A, Dumas P-Y, Drullion C, Guitart A, Villacreces A, Peytour Y, et al. Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence. Oncotarget. 2017;8(57):96984.","journal-title":"Oncotarget"},{"issue":"10","key":"3999_CR112","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1038\/leu.2015.112","volume":"29","author":"L Mourgues","year":"2015","unstructured":"Mourgues L, Imbert V, Nebout M, Colosetti P, Neffati Z, Lagadec P, et al. The BMI1 polycomb protein represses cyclin G2-induced autophagy to support proliferation in chronic myeloid leukemia cells. Leukemia. 2015;29(10):1993\u20132002.","journal-title":"Leukemia"},{"issue":"10","key":"3999_CR113","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/ng.3380","volume":"47","author":"J Saliba","year":"2015","unstructured":"Saliba J, Saint-Martin C, Di Stefano A, Lenglet G, Marty C, Keren B, et al. Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies. Nat Genet. 2015;47(10):1131\u201340.","journal-title":"Nat Genet"},{"issue":"4","key":"3999_CR114","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molcel.2016.04.011","volume":"62","author":"SM Park","year":"2016","unstructured":"Park SM, Ou J, Chamberlain L, Simone TM, Yang H, Virbasius C-M, et al. U2AF35 (S34F) promotes transformation by directing aberrant ATG7 pre-mRNA 3\u2032 end formation. Mol Cell. 2016;62(4):479\u201390.","journal-title":"Mol Cell"},{"issue":"1","key":"3999_CR115","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6328051","volume":"2018","author":"H Jiang","year":"2018","unstructured":"Jiang H, Yang L, Guo L, Cui N, Zhang G, Liu C, et al. Impaired mitophagy of nucleated erythroid cells leads to anemia in patients with myelodysplastic syndromes. Oxid Med Cell Longev. 2018;2018(1):6328051.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"3999_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.210","volume":"7","author":"Y Su","year":"2016","unstructured":"Su Y, Wu H, Pavlosky A, Zou L-L, Deng X, Zhang Z-X, et al. Regulatory non-coding RNA: new instruments in the orchestration of cell death. Cell Death Dis. 2016;7(8):e2333\u2013e.","journal-title":"Cell Death Dis"},{"issue":"45","key":"3999_CR117","doi-asserted-by":"publisher","first-page":"17719","DOI":"10.1073\/pnas.0703890104","volume":"104","author":"HK Saini","year":"2007","unstructured":"Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci U S A. 2007;104(45):17719\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"3999_CR118","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1101\/gad.1352605","volume":"19","author":"M Yoshikawa","year":"2005","unstructured":"Yoshikawa M, Peragine A, Park MY, Poethig RS. A pathway for the biogenesis of trans-acting siRNAs in Arabidopsis. Genes Dev. 2005;19(18):2164\u201375.","journal-title":"Genes Dev"},{"issue":"5725","key":"3999_CR119","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1126\/science.1108625","volume":"308","author":"J Cheng","year":"2005","unstructured":"Cheng J, Kapranov P, Drenkow J, Dike S, Brubaker S, Patel S, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308(5725):1149\u201354.","journal-title":"Science"},{"issue":"2","key":"3999_CR120","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/path.2638","volume":"220","author":"RJ Taft","year":"2010","unstructured":"Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding rnas: regulators of disease. J Pathology: J Pathological Soc Great Br Irel. 2010;220(2):126\u201339.","journal-title":"J Pathology: J Pathological Soc Great Br Irel"},{"key":"3999_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of microrna biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"3999_CR122","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/nsmb.2125","volume":"18","author":"A Tsutsumi","year":"2011","unstructured":"Tsutsumi A, Kawamata T, Izumi N, Seitz H, Tomari Y. Recognition of the pre-miRNA structure by drosophila Dicer-1. Nat Struct Mol Biol. 2011;18(10):1153\u20138.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"3999_CR123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0092-8674(04)00261-2","volume":"117","author":"YS Lee","year":"2004","unstructured":"Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ, et al. Distinct roles for drosophila Dicer-1 and Dicer-2 in the siRNA\/miRNA silencing pathways. Cell. 2004;117(1):69\u201381.","journal-title":"Cell"},{"issue":"4","key":"3999_CR124","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1242\/jcs.059659","volume":"123","author":"Y Kawase-Koga","year":"2010","unstructured":"Kawase-Koga Y, Low R, Otaegi G, Pollock A, Deng H, Eisenhaber F, et al. RNAase-III enzyme dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells. J Cell Sci. 2010;123(4):586\u201394.","journal-title":"J Cell Sci"},{"issue":"2","key":"3999_CR125","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ydbio.2010.01.039","volume":"340","author":"A Zehir","year":"2010","unstructured":"Zehir A, Hua LL, Maska EL, Morikawa Y, Cserjesi P. Dicer is required for survival of differentiating neural crest cells. Dev Biol. 2010;340(2):459\u201367.","journal-title":"Dev Biol"},{"issue":"2","key":"3999_CR126","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ccell.2015.01.002","volume":"27","author":"J Wegert","year":"2015","unstructured":"Wegert J, Ishaque N, Vardapour R, Ge\u00f6rg C, Gu Z, Bieg M, et al. Mutations in the SIX1\/2 pathway and the DROSHA\/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors. Cancer Cell. 2015;27(2):298\u2013311.","journal-title":"Cancer Cell"},{"issue":"2","key":"3999_CR127","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ccell.2015.01.003","volume":"27","author":"AL Walz","year":"2015","unstructured":"Walz AL, Ooms A, Gadd S, Gerhard DS, Smith MA, Auvil JMG, et al. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors. Cancer Cell. 2015;27(2):286\u201397.","journal-title":"Cancer Cell"},{"issue":"6","key":"3999_CR128","first-page":"1568","volume":"125","author":"R Singh","year":"2012","unstructured":"Singh R, Saini N. Downregulation of BCL2 by miRNAs augments drug-induced apoptosis\u2013a combined computational and experimental approach. J Cell Sci. 2012;125(6):1568\u201378.","journal-title":"J Cell Sci"},{"issue":"1","key":"3999_CR129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/cvr\/cvr145","volume":"92","author":"H Zhu","year":"2011","unstructured":"Zhu H, Yang Y, Wang Y, Li J, Schiller PW, Peng T. Microrna-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc Res. 2011;92(1):75\u201384.","journal-title":"Cardiovasc Res"},{"issue":"11","key":"3999_CR130","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1002\/ijc.25260","volume":"127","author":"W Zhu","year":"2010","unstructured":"Zhu W, Shan X, Wang T, Shu Y, Liu P. Mir-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer. 2010;127(11):2520\u20139.","journal-title":"Int J Cancer"},{"issue":"26","key":"3999_CR131","doi-asserted-by":"publisher","first-page":"20281","DOI":"10.1074\/jbc.M110.109207","volume":"285","author":"D Sayed","year":"2010","unstructured":"Sayed D, He M, Hong C, Gao S, Rane S, Yang Z, et al. Microrna-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285(26):20281\u201390.","journal-title":"J Biol Chem"},{"issue":"12","key":"3999_CR132","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/glia.22404","volume":"60","author":"L Zhang","year":"2012","unstructured":"Zhang L, Dong LY, Li YJ, Hong Z, Wei WS. Mir-21 represses FasL in microglia and protects against microglia\u2010mediated neuronal cell death following hypoxia\/ischemia. Glia. 2012;60(12):1888\u201395.","journal-title":"Glia"},{"issue":"40","key":"3999_CR133","doi-asserted-by":"publisher","first-page":"27526","DOI":"10.1074\/jbc.M114.602383","volume":"289","author":"H Francis","year":"2014","unstructured":"Francis H, McDaniel K, Han Y, Liu X, Kennedy L, Yang F, et al. Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury. J Biol Chem. 2014;289(40):27526\u201339.","journal-title":"J Biol Chem"},{"issue":"6","key":"3999_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005848","volume":"4","author":"R Chhabra","year":"2009","unstructured":"Chhabra R, Adlakha YK, Hariharan M, Scaria V, Saini N. Upregulation of miR-23a\u223c 27a\u223c 24\u2009\u2013\u20092 cluster induces caspase-dependent and-independent apoptosis in human embryonic kidney cells. PLoS ONE. 2009;4(6):e5848.","journal-title":"PLoS ONE"},{"issue":"8","key":"3999_CR135","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.ijom.2013.04.016","volume":"42","author":"J Wang","year":"2013","unstructured":"Wang J, Huang H, Wang C, Liu X, Hu F, Liu M. Microrna-375 sensitizes tumour necrosis factor-alpha (TNF-\u03b1)-induced apoptosis in head and neck squamous cell carcinoma in vitro. Int J Oral Maxillofac Surg. 2013;42(8):949\u201355.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"7","key":"3999_CR136","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1111\/j.1582-4934.2010.01104.x","volume":"15","author":"J Liu","year":"2011","unstructured":"Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH, et al. MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med. 2011;15(7):1474\u201382.","journal-title":"J Cell Mol Med"},{"issue":"7338","key":"3999_CR137","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature09857","volume":"471","author":"WJ Kaiser","year":"2011","unstructured":"Kaiser WJ, Upton JW, Long AB, Livingston-Rosanoff D, Daley-Bauer LP, Hakem R, et al. RIP3 mediates the embryonic lethality of caspase-8-deficient mice. Nature. 2011;471(7338):368\u201372.","journal-title":"Nature"},{"issue":"1","key":"3999_CR138","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2011.02.023","volume":"145","author":"S Biton","year":"2011","unstructured":"Biton S, Ashkenazi A. NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-\u03b1 feedforward signaling. Cell. 2011;145(1):92\u2013103.","journal-title":"Cell"},{"issue":"7","key":"3999_CR139","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.233","volume":"4","author":"K Wang","year":"2013","unstructured":"Wang K, Liu F, Zhou L, Ding S, Long B, Liu C, et al. Mir-874 regulates myocardial necrosis by targeting caspase-8. Cell Death Dis. 2013;4(7):e709\u2013e.","journal-title":"Cell Death Dis"},{"key":"3999_CR140","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cca.2022.10.018","volume":"537","author":"A Movahedpour","year":"2022","unstructured":"Movahedpour A, Khatami SH, Karami N, Vakili O, Naeli P, Jamali Z, et al. Exosomal noncoding RNAs in prostate cancer. Clin Chim Acta. 2022;537:127\u201332.","journal-title":"Clin Chim Acta"},{"key":"3999_CR141","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.canlet.2021.03.018","volume":"508","author":"S Ashrafizaveh","year":"2021","unstructured":"Ashrafizaveh S, Ashrafizadeh M, Zarrabi A, Husmandi K, Zabolian A, Shahinozzaman M, et al. Long non-coding RNAs in the doxorubicin resistance of cancer cells. Cancer Lett. 2021;508:104\u201314.","journal-title":"Cancer Lett"},{"issue":"7","key":"3999_CR142","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/febs.12737","volume":"281","author":"Y Fan","year":"2014","unstructured":"Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y. Long non-coding RNA UCA 1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014;281(7):1750\u20138.","journal-title":"FEBS J"},{"issue":"9","key":"3999_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073920","volume":"8","author":"W Wu","year":"2013","unstructured":"Wu W, Zhang S, Li X, Xue M, Cao S, Chen W. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS ONE. 2013;8(9):e73920.","journal-title":"PLoS ONE"},{"key":"3999_CR144","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.16.5516-5525.2003","author":"N El-Guendy","year":"2003","unstructured":"El-Guendy N, Zhao Y, Gurumurthy S, Burikhanov R, Rangnekar VM. Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cells. Mol Cell Biol. 2003;23(16):5516\u201325. https:\/\/doi.org\/10.1128\/MCB.23.16.5516-5525.2003","journal-title":"Mol Cell Biol"},{"issue":"6","key":"3999_CR145","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3109\/10428194.2013.829574","volume":"55","author":"L Zhang","year":"2014","unstructured":"Zhang L, Xu H-G, Lu C. A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leuk Lymphoma. 2014;55(6):1373\u201382.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"3999_CR146","doi-asserted-by":"publisher","first-page":"664","DOI":"10.7150\/ijbs.8232","volume":"10","author":"W-H Xu","year":"2014","unstructured":"Xu W-H, Zhang J-B, Dang Z, Li X, Zhou T, Liu J, et al. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK\/MAPK signaling pathway in hepatocellular carcinoma. Int J Biol Sci. 2014;10(7):664.","journal-title":"Int J Biol Sci"},{"issue":"10","key":"3999_CR147","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/jcb.24586","volume":"114","author":"H Zhao","year":"2013","unstructured":"Zhao H, Zhang X, Fraz\u00e3o JB, Condino-Neto A, Newburger PE. HOX antisense LincRNA HOXA\u2010AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J Cell Biochem. 2013;114(10):2375\u201383.","journal-title":"J Cell Biochem"},{"issue":"11","key":"3999_CR148","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-10-4460","volume":"71","author":"D Khaitan","year":"2011","unstructured":"Khaitan D, Dinger ME, Mazar J, Crawford J, Smith MA, Mattick JS, Perera RJ. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res. 2011;71(11):3852\u201362.","journal-title":"Cancer Res"},{"issue":"5","key":"3999_CR149","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2013.01.019","volume":"144","author":"W Wu","year":"2013","unstructured":"Wu W, Bhagat TD, Yang X, Song JH, Cheng Y, Agarwal R, et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in barrett\u2019s esophagus and esophageal adenocarcinoma. Gastroenterology. 2013;144(5):956\u201366. e4.","journal-title":"Gastroenterology"},{"key":"3999_CR150","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10620-013-2956-7","volume":"59","author":"C-M Wang","year":"2014","unstructured":"Wang C-M, Wu Q-Q, Li S-Q, Chen F-J, Tuo L, Xie H-W, et al. Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage. Dig Dis Sci. 2014;59:591\u20137.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"3999_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080817","volume":"8","author":"Z Chen","year":"2013","unstructured":"Chen Z, Jia S, Li D, Cai J, Tu J, Geng B, et al. Silencing of long noncoding RNA AK139328 attenuates ischemia\/reperfusion injury in mouse livers. PLoS ONE. 2013;8(11):e80817.","journal-title":"PLoS ONE"},{"issue":"3","key":"3999_CR152","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/ejcts\/ezu215","volume":"47","author":"S Wang","year":"2015","unstructured":"Wang S, Zhang X, Yuan Y, Tan M, Zhang L, Xue X, et al. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardiothorac Surg. 2015;47(3):439\u201346.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"10","key":"3999_CR153","first-page":"1613","volume":"1832","author":"M Pickard","year":"2013","unstructured":"Pickard M, Mourtada-Maarabouni M, Williams G. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Et Biophys Acta (BBA)-Molecular Basis Disease. 2013;1832(10):1613\u201323.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Basis Disease"},{"issue":"12","key":"3999_CR154","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.bcp.2013.04.020","volume":"85","author":"H Yang","year":"2013","unstructured":"Yang H, Zhong Y, Xie H, Lai X, Xu M, Nie Y, et al. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem Pharmacol. 2013;85(12):1761\u20139.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"3999_CR155","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/jcb.25004","volume":"116","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zou Y, Wang W, Zuo Q, Jiang Z, Sun M, et al. Down-regulated long non\u2010coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells. J Cell Biochem. 2015;116(4):542\u201350.","journal-title":"J Cell Biochem"},{"issue":"11","key":"3999_CR156","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/mc.22215","volume":"54","author":"X Ma Mz, Kong","year":"2015","unstructured":"Ma Mz, Kong X, Weng Mz Z, Md Q, Yy, Gong W, et al. Long non-coding RNA\u2010LET is a positive prognostic factor and exhibits tumor\u2010suppressive activity in gallbladder cancer. Mol Carcinog. 2015;54(11):1397\u2013406.","journal-title":"Mol Carcinog"},{"issue":"6","key":"3999_CR157","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/1947601910377798","volume":"1","author":"DW Felsher","year":"2010","unstructured":"Felsher DW. MYC inactivation elicits oncogene addiction through both tumor cell\u2013intrinsic and host-dependent mechanisms. Genes Cancer. 2010;1(6):597\u2013604.","journal-title":"Genes Cancer"},{"issue":"8","key":"3999_CR158","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ncponc0558","volume":"3","author":"IB Weinstein","year":"2006","unstructured":"Weinstein IB, Joe AK. Mechanisms of disease: oncogene addiction\u2014a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol. 2006;3(8):448\u201357.","journal-title":"Nat Clin Pract Oncol"},{"issue":"38","key":"3999_CR159","doi-asserted-by":"publisher","first-page":"E5261","DOI":"10.1073\/pnas.1505753112","volume":"112","author":"G Doose","year":"2015","unstructured":"Doose G, Haake A, Bernhart SH, L\u00f3pez C, Duggimpudi S, Wojciech F, et al. MINCR is a MYC-induced lncRNA able to modulate MYC\u2019s transcriptional network in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 2015;112(38):E5261\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"3999_CR160","doi-asserted-by":"publisher","first-page":"9497","DOI":"10.1007\/s13277-014-2511-y","volume":"35","author":"K Deng","year":"2014","unstructured":"Deng K, Guo X, Wang H, Xia J. The lncRNA-MYC regulatory network in cancer. Tumor Biol. 2014;35(10):9497\u2013503.","journal-title":"Tumor Biol"},{"issue":"2","key":"3999_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053823","volume":"8","author":"S Jalali","year":"2013","unstructured":"Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS ONE. 2013;8(2):e53823.","journal-title":"PLoS ONE"},{"issue":"1","key":"3999_CR162","first-page":"595","volume":"19","author":"B Sun","year":"2020","unstructured":"Sun B, Liu C, Li H, Zhang L, Luo G, Liang S, et al. Research progress on the interactions between long non-coding RNAs and microRNAs in human cancer. Oncol Lett. 2020;19(1):595\u2013605.","journal-title":"Oncol Lett"},{"key":"3999_CR163","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1038\/srep13445","volume":"5","author":"T Xia","year":"2015","unstructured":"Xia T, Chen S, Jiang Z, Shao Y, Jiang X, Li P, et al. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci Rep. 2015;5:13445.","journal-title":"Sci Rep"},{"issue":"5","key":"3999_CR164","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2014.03.045","volume":"54","author":"R Denzler","year":"2014","unstructured":"Denzler R, Agarwal V, Stefano J, Bartel DP, Stoffel M. Assessing the CeRNA hypothesis with quantitative measurements of MiRNA and target abundance. Mol Cell. 2014;54(5):766\u201376.","journal-title":"Mol Cell"},{"issue":"16","key":"3999_CR165","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1093\/nar\/gkq285","volume":"38","author":"J Wang","year":"2010","unstructured":"Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 2010;38(16):5366\u201383.","journal-title":"Nucleic Acids Res"},{"key":"3999_CR166","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-014-0072-y","volume":"33","author":"J-H He","year":"2014","unstructured":"He J-H, Zhang J-z, Han Z-P, Wang L, Lv YB, Li Y-G. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res. 2014;33:1\u201310.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"3999_CR167","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1093\/nar\/gkt182","volume":"41","author":"Q Liu","year":"2013","unstructured":"Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41(9):4976\u201387.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3999_CR168","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta stone of a hidden RNA. language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"issue":"1","key":"3999_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01494-0","volume":"22","author":"E Heydarnia","year":"2024","unstructured":"Heydarnia E, Dorostgou Z, Hedayati N, Mousavi V, Yahyazadeh S, Alimohammadi M, et al. Circular rnas and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms. Cell Commun Signal. 2024;22(1):107.","journal-title":"Cell Commun Signal"},{"key":"3999_CR170","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1149187","volume":"13","author":"A Rahmati","year":"2023","unstructured":"Rahmati A, Mafi A, Soleymani F, Babaei Aghdam Z, Masihipour N, Ghezelbash B, et al. Circular rnas: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. Front Oncol. 2023;13:1149187.","journal-title":"Front Oncol"},{"issue":"9","key":"3999_CR171","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/jnr.25094","volume":"100","author":"Z Dorostgou","year":"2022","unstructured":"Dorostgou Z, Yadegar N, Dorostgou Z, Khorvash F, Vakili O. Novel insights into the role of circular RNAs in Parkinson disease: an emerging renaissance in the management of neurodegenerative diseases. J Neurosci Res. 2022;100(9):1775\u201390.","journal-title":"J Neurosci Res"},{"key":"3999_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135659","author":"Y Gao","year":"2024","unstructured":"Gao Y, Lin H, Tang T, Wang Y, Chen W, Li L. Circular rnas in programmed cell death: regulation mechanisms and potential clinical applications in cancer: a review. Int J Biol Macromol. 2024;280:135659. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135659","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3999_CR173","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1080\/21655979.2022.2037870","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Xu Y, Zheng Q. Circrna_0000285 knockdown suppresses viability and promotes apoptosis of cervical cancer cells by sponging microrna-654-3p. Bioengineered. 2022;13(3):5251\u201361.","journal-title":"Bioengineered"},{"issue":"20","key":"3999_CR174","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1080\/15384101.2020.1814026","volume":"19","author":"D Sun","year":"2020","unstructured":"Sun D, Zhu D. Circular RNA hsa_circ_0001649 suppresses the growth of osteosarcoma cells via sponging multiple miRNAs. Cell Cycle. 2020;19(20):2631\u201343.","journal-title":"Cell Cycle"},{"issue":"9","key":"3999_CR175","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1631\/jzus.B2200048","volume":"23","author":"X Li","year":"2022","unstructured":"Li X, Zhang Y, Wang N, Yuan Z, Chen X, Chen Q, et al. Circrna. 0007127 triggers apoptosis through the miR-513a-5p\/CASP8 axis in K-562 cells. Journal of Zhejiang University-SCIENCE B. 2022;23(9):732\u201346.","journal-title":"Journal of Zhejiang University-SCIENCE B"},{"key":"3999_CR176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01152-2","volume":"19","author":"G Liang","year":"2020","unstructured":"Liang G, Ling Y, Mehrpour M, Saw PE, Liu Z, Tan W, et al. Autophagy-associated circrna circcdyl augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19:1\u201316.","journal-title":"Mol Cancer"},{"issue":"8","key":"3999_CR177","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41419-021-04053-4","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Mou Z, Xu C, Wu S, Dai X, Chen X, et al. Autophagy-associated circular RNA hsa_circ_0007813 modulates human bladder cancer progression via hsa-miR-361-3p\/IGF2R regulation. Cell Death Dis. 2021;12(8):778.","journal-title":"Cell Death Dis"},{"key":"3999_CR178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01183-9","volume":"19","author":"X Zheng","year":"2020","unstructured":"Zheng X, Huang M, Xing L, Yang R, Wang X, Jiang R, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19:1\u201322.","journal-title":"Mol Cancer"},{"key":"3999_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01279-2","volume":"19","author":"W Gao","year":"2020","unstructured":"Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020;19:1\u201322.","journal-title":"Mol Cancer"},{"key":"3999_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01163-z","volume":"19","author":"X Gan","year":"2020","unstructured":"Gan X, Zhu H, Jiang X, Obiegbusi SC, Yong M, Long X, Hu J. CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a. Mol Cancer. 2020;19:1\u201313.","journal-title":"Mol Cancer"},{"key":"3999_CR181","doi-asserted-by":"crossref","unstructured":"Sun M, Zhao W, Zhang B, Geng D, Li S, Bu R, Liu X. Overexpressed circ-CEP128, a potential new circular RNA biomarker, promotes cisplatin resistance of bladder cancer cells by regulating necroptosis. 2020.","DOI":"10.21203\/rs.3.rs-44293\/v1"},{"issue":"3","key":"3999_CR182","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41418-021-00872-2","volume":"29","author":"X-Q Gao","year":"2022","unstructured":"Gao X-Q, Liu C-Y, Zhang Y-H, Wang Y-H, Zhou L-Y, Li X-M, et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression. Cell Death Differ. 2022;29(3):527\u201339.","journal-title":"Cell Death Differ"},{"key":"3999_CR183","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.9.2330","author":"A Nechushtan","year":"1999","unstructured":"Nechushtan A, Smith CL, Hsu YT, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 1999;18:2330\u201341. https:\/\/doi.org\/10.1093\/emboj\/18.9.2330","journal-title":"EMBO J"},{"issue":"5","key":"3999_CR184","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1083\/jcb.139.5.1281","volume":"139","author":"KG Wolter","year":"1997","unstructured":"Wolter KG, Hsu Y-T, Smith CL, Nechushtan A, Xi X-G, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139(5):1281\u201392.","journal-title":"J Cell Biol"},{"issue":"14","key":"3999_CR185","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1093\/emboj\/17.14.3878","volume":"17","author":"A Gross","year":"1998","unstructured":"Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 1998;17(14):3878\u201385.","journal-title":"EMBO J"},{"issue":"1","key":"3999_CR186","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000338149","volume":"122","author":"X Duan","year":"2012","unstructured":"Duan X, Ji B, Wang X, Liu J, Zheng Z, Long C, et al. Expression of microrna-1 and microrna-21 in different protocols of ischemic conditioning in an isolated rat heart model. Cardiology. 2012;122(1):36\u201343.","journal-title":"Cardiology"},{"key":"3999_CR187","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s11033-013-2891-x","volume":"41","author":"J Yang","year":"2014","unstructured":"Yang J, Chen L, Yang J, Ding J, Li S, Wu H, et al. Microrna-22 targeting CBP protects against myocardial ischemia\u2013reperfusion injury through anti-apoptosis in rats. Mol Biol Rep. 2014;41:555\u201361.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3999_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085389","volume":"9","author":"L Wang","year":"2014","unstructured":"Wang L, Qian L. Mir-24 regulates intrinsic apoptosis pathway in mouse cardiomyocytes. PLoS ONE. 2014;9(1):e85389.","journal-title":"PLoS ONE"},{"issue":"30","key":"3999_CR189","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1523\/JNEUROSCI.1260-14.2014","volume":"34","author":"B Sabirzhanov","year":"2014","unstructured":"Sabirzhanov B, Zhao Z, Stoica BA, Loane DJ, Wu J, Borroto C, et al. Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins. J Neurosci. 2014;34(30):10055\u201371.","journal-title":"J Neurosci"},{"issue":"3","key":"3999_CR190","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005;17(3):393\u2013403.","journal-title":"Mol Cell"},{"issue":"17","key":"3999_CR191","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1101\/gad.245621.114","volume":"28","author":"B Pernaute","year":"2014","unstructured":"Pernaute B, Spruce T, Smith KM, S\u00e1nchez-Nieto JM, Manzanares M, Cobb B, et al. Micrornas control the apoptotic threshold in primed pluripotent stem cells through regulation of BIM. Genes Dev. 2014;28(17):1873\u20138.","journal-title":"Genes Dev"},{"issue":"3","key":"3999_CR192","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1084\/jem.20101547","volume":"208","author":"L Qian","year":"2011","unstructured":"Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. MiR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 2011;208(3):549\u201360.","journal-title":"J Exp Med"},{"issue":"4","key":"3999_CR193","first-page":"978","volume":"126","author":"L Guo","year":"2013","unstructured":"Guo L, Xu J, Qi J, Zhang L, Wang J, Liang J, et al. MicroRNA-17-92a upregulation by Estrogen leads to Bim targeting and Inhibition of osteoblast apoptosis. J Cell Sci. 2013;126(4):978\u201388.","journal-title":"J Cell Sci"},{"key":"3999_CR194","doi-asserted-by":"crossref","unstructured":"Deshmukh M, Kuida K, Johnson EM Jr. Caspase inhibition extends the commitment to neuronal death beyond cytochrome c release to the point of mitochondrial depolarization. J Cell Biol. 2000;150(1):131\u201344.","DOI":"10.1083\/jcb.150.1.131"},{"issue":"3","key":"3999_CR195","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1038\/cddis.2014.92","volume":"5","author":"Q Chen","year":"2014","unstructured":"Chen Q, Xu J, Li L, Li H, Mao S, Zhang F, et al. MicroRNA-23a\/b and microRNA-27a\/b suppress Apaf-1 protein and alleviate hypoxia-induced neuronal apoptosis. Cell Death Dis. 2014;5(3):e1132\u2013e.","journal-title":"Cell Death Dis"},{"key":"3999_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1423-0127-18-22","volume":"18","author":"B He","year":"2011","unstructured":"He B, Xiao J, Ren A-J, Zhang Y-F, Zhang H, Chen M, et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011;18:1\u201310.","journal-title":"J Biomed Sci"},{"key":"3999_CR197","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s10495-011-0683-0","volume":"17","author":"J Fang","year":"2012","unstructured":"Fang J, Song X-W, Tian J, Chen H-Y, Li D-F, Wang J-F, et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis. 2012;17:410\u201323.","journal-title":"Apoptosis"},{"issue":"10","key":"3999_CR198","doi-asserted-by":"publisher","first-page":"8091","DOI":"10.1074\/jbc.M204783200","volume":"278","author":"H Zou","year":"2003","unstructured":"Zou H, Yang R, Hao J, Wang J, Sun C, Fesik SW, et al. Regulation of the Apaf-1\/caspase-9 apoptosome by caspase-3 and XIAP. J Biol Chem. 2003;278(10):8091\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"3999_CR199","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","volume":"137","author":"J-P Kruse","year":"2009","unstructured":"Kruse J-P, Gu W. Modes of p53 regulation. Cell. 2009;137(4):609\u201322.","journal-title":"Cell"},{"issue":"1\u20132","key":"3999_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2007.01.029","volume":"395","author":"M-J Halaby","year":"2007","unstructured":"Halaby M-J, Yang D-Q. P53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene. 2007;395(1\u20132):1\u20137.","journal-title":"Gene"},{"issue":"3","key":"3999_CR201","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jmcb\/mju013","volume":"6","author":"A Zhang","year":"2014","unstructured":"Zhang A, Xu M, Mo Y-Y. Role of the lncRNA\u2013p53 regulatory network in cancer. J Mol Cell Biol. 2014;6(3):181\u201391.","journal-title":"J Mol Cell Biol"},{"issue":"3","key":"3999_CR202","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1210\/en.2009-0657","volume":"151","author":"X Zhang","year":"2010","unstructured":"Zhang X, Rice K, Wang Y, Chen W, Zhong Y, Nakayama Y, et al. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology. 2010;151(3):939\u201347.","journal-title":"Endocrinology"},{"issue":"6","key":"3999_CR203","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A, Zhong Y, Rice KA, Zhou Y, et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res. 2010;70(6):2350\u20138.","journal-title":"Cancer Res"},{"issue":"34","key":"3999_CR204","doi-asserted-by":"publisher","first-page":"24731","DOI":"10.1074\/jbc.M702029200","volume":"282","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, et al. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007;282(34):24731\u201342.","journal-title":"J Biol Chem"},{"issue":"3","key":"3999_CR205","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003368","volume":"9","author":"V Tripathi","year":"2013","unstructured":"Tripathi V, Shen Z, Chakraborty A, Giri S, Freier SM, Wu X, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013;9(3):e1003368.","journal-title":"PLoS Genet"},{"issue":"3","key":"3999_CR206","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/cr.2012.164","volume":"23","author":"A Zhang","year":"2013","unstructured":"Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, Ma D, et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res. 2013;23(3):340\u201350.","journal-title":"Cell Res"},{"issue":"12","key":"3999_CR207","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.710","volume":"42","author":"S Loewer","year":"2010","unstructured":"Loewer S, Cabili MN, Guttman M, Loh Y-H, Thomas K, Park IH, et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010;42(12):1113\u20137.","journal-title":"Nat Genet"},{"key":"3999_CR208","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.exphem.2018.08.005","volume":"67","author":"S Gao","year":"2018","unstructured":"Gao S, Zhou B, Li H, Huang X, Wu Y, Xing C, et al. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic Silencing of p15. Exp Hematol. 2018;67:32\u201340. e3.","journal-title":"Exp Hematol"},{"issue":"10","key":"3999_CR209","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1078-8","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Yang X, Sun X, Rong L, Kang M, Wu P, et al. Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia. Cell Death Dis. 2018;9(10):1043.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3999_CR210","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/s41375-019-0429-5","volume":"33","author":"M Bill","year":"2019","unstructured":"Bill M, Papaioannou D, Karunasiri M, Kohlschmidt J, Pepe F, Walker CJ, et al. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells. Leukemia. 2019;33(9):2169\u201382.","journal-title":"Leukemia"},{"key":"3999_CR211","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.gene.2019.03.055","volume":"707","author":"N El-Khazragy","year":"2019","unstructured":"El-Khazragy N, Elayat W, Matbouly S, Seliman S, Sami A, Safwat G, Diab A. The prognostic significance of the long non-coding RNAs CCAT1, PVT1 in t (8; 21) associated acute myeloid leukemia. Gene. 2019;707:172\u20137.","journal-title":"Gene"},{"issue":"10a","key":"3999_CR212","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14(10a):1902\u201310.","journal-title":"Genome Res"},{"issue":"8","key":"3999_CR213","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1093\/nar\/gki567","volume":"33","author":"Y Altuvia","year":"2005","unstructured":"Altuvia Y, Landgraf P, Lithwick G, Elefant N, Pfeffer S, Aravin A, et al. Clustering and conservation patterns of human MicroRNAs. Nucleic Acids Res. 2005;33(8):2697\u2013706.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"3999_CR214","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101(9):2999\u20133004.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3999_CR215","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1182\/blood-2010-03-277012","volume":"117","author":"DT Starczynowski","year":"2011","unstructured":"Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, Wegrzyn J, et al. Genome-wide identification of human MicroRNAs located in leukemia-associated genomic alterations. Blood. 2011;117(2):595\u2013607.","journal-title":"Blood"},{"issue":"7","key":"3999_CR216","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","volume":"74","author":"DC De Leeuw","year":"2014","unstructured":"De Leeuw DC, Denkers F, Olthof MC, Rutten AP, Pouwels W, Jan Schuurhuis G, et al. Attenuation of microRNA-126 expression that drives CD34\u2009+\u200938\u2009\u2013\u2009stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74(7):2094\u2013105.","journal-title":"Cancer Res"},{"issue":"6","key":"3999_CR217","doi-asserted-by":"publisher","first-page":"e2849","DOI":"10.1038\/cddis.2017.253","volume":"8","author":"L De Luca","year":"2017","unstructured":"De Luca L, Trino S, Laurenzana I, Tagliaferri D, Falco G, Grieco V, et al. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia. Cell Death Dis. 2017;8(6):e2849\u2013e.","journal-title":"Cell Death Dis"},{"issue":"13","key":"3999_CR218","first-page":"2878","volume":"20","author":"S Wang","year":"2016","unstructured":"Wang S, Wang T, Li M, Cheng X, Li X. Expression of microrna miR-34a inhibits leukemia stem cells and its metastasis. Eur Rev Med Pharmacol Sci. 2016;20(13):2878\u201383.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3999_CR219","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2018.11.036","volume":"844","author":"S Gan","year":"2019","unstructured":"Gan S, Ma P, Ma J, Wang W, Han H, Chen L, et al. Knockdown of ZFAS1 suppresses the progression of acute myeloid leukemia by regulating microRNA-150\/Sp1 and microRNA-150\/Myb pathways. Eur J Pharmacol. 2019;844:38\u201348.","journal-title":"Eur J Pharmacol"},{"key":"3999_CR220","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","volume":"34","author":"Z-y Li","year":"2018","unstructured":"Li Z-y, Yang L, Liu X-j, Wang X-z, Pan Y-x, Luo J-m. The long noncoding RNA MEG3 and its target miR-147 regulate JAK\/STAT pathway in advanced chronic myeloid leukemia. EBioMedicine. 2018;34:61\u201375.","journal-title":"EBioMedicine"},{"issue":"1","key":"3999_CR221","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/dna.2016.3533","volume":"36","author":"Y Xiao","year":"2017","unstructured":"Xiao Y, Jiao C, Lin Y, Chen M, Zhang J, Wang J, et al. LncRNA UCA1 contributes to Imatinib resistance by acting as a ceRNA against miR-16 in chronic myeloid leukemia cells. DNA Cell Biol. 2017;36(1):18\u201325.","journal-title":"DNA Cell Biol"},{"issue":"5","key":"3999_CR222","doi-asserted-by":"publisher","first-page":"490","DOI":"10.4062\/biomolther.2016.162","volume":"25","author":"X Zhou","year":"2017","unstructured":"Zhou X, Yuan P, Liu Q, Liu Z. LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21. Biomol Ther. 2017;25(5):490.","journal-title":"Biomol Ther"},{"issue":"4","key":"3999_CR223","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41419-019-1479-3","volume":"10","author":"C-C Zhao","year":"2019","unstructured":"Zhao C-C, Jiao Y, Zhang Y-Y, Ning J, Zhang Y-R, Xu J, et al. Lnc SMAD5-AS1 as CeRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt\/\u03b2-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Cell Death Dis. 2019;10(4):252.","journal-title":"Cell Death Dis"},{"issue":"18","key":"3999_CR224","doi-asserted-by":"publisher","first-page":"10352","DOI":"10.1039\/C9RA00142E","volume":"9","author":"N Hu","year":"2019","unstructured":"Hu N, Chen L, Li Q, Zhao H. LncRNA HOTAIRM1 is involved in the progression of acute myeloid leukemia through targeting miR-148b. RSC Adv. 2019;9(18):10352\u20139.","journal-title":"RSC Adv"},{"issue":"1","key":"3999_CR225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00212-4","volume":"8","author":"A Schwarzer","year":"2017","unstructured":"Schwarzer A, Emmrich S, Schmidt F, Beck D, Ng M, Reimer C, et al. The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun. 2017;8(1):1\u201317.","journal-title":"Nat Commun"},{"issue":"3","key":"3999_CR226","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cell.2014.05.049","volume":"158","author":"T Trimarchi","year":"2014","unstructured":"Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, Aifantis I. Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell. 2014;158(3):593\u2013606.","journal-title":"Cell"},{"issue":"5","key":"3999_CR227","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1158\/1541-7786.MCR-15-0006-T","volume":"13","author":"TR Fernando","year":"2015","unstructured":"Fernando TR, Rodriguez-Malave NI, Waters EV, Yan W, Casero D, Basso G, et al. LncRNA expression discriminates karyotype and predicts survival in B-lymphoblastic leukemia. Mol Cancer Res. 2015;13(5):839\u201351.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"3999_CR228","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yexcr.2018.06.026","volume":"370","author":"G Xiao","year":"2018","unstructured":"Xiao G, Li Y, Wang Y, Zhao B, Zou Z, Hou S, et al. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity. Exp Cell Res. 2018;370(2):254\u201363.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3999_CR229","doi-asserted-by":"publisher","first-page":"60","DOI":"10.18632\/oncotarget.26538","volume":"10","author":"RC Tschumper","year":"2019","unstructured":"Tschumper RC, Shanafelt TD, Kay NE, Jelinek DF. Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia. Oncotarget. 2019;10(1):60.","journal-title":"Oncotarget"},{"issue":"6","key":"3999_CR230","first-page":"4935","volume":"17","author":"X Shi","year":"2019","unstructured":"Shi X, Li J, Ma L, Wen L, Wang Q, Yao H, et al. Overexpression of ZEB2\u2013AS1 LncRNA is associated with poor clinical outcomes in acute myeloid leukemia. Oncol Lett. 2019;17(6):4935\u201347.","journal-title":"Oncol Lett"},{"issue":"2","key":"3999_CR231","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2141.2007.06915.x","volume":"140","author":"F Isken","year":"2008","unstructured":"Isken F, Steffen B, Merk S, Dugas M, Markus B, Tidow N, et al. Identification of acute myeloid leukaemia associated microRNA expression patterns. Br J Haematol. 2008;140(2):153\u201361.","journal-title":"Br J Haematol"},{"issue":"5","key":"3999_CR232","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/CCO.0000000000000657","volume":"32","author":"Z Han","year":"2020","unstructured":"Han Z, Rosen ST, Querfeld C. Targeting microrna in hematologic malignancies. Curr Opin Oncol. 2020;32(5):535\u201344.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"3999_CR233","volume":"29","author":"V Innao","year":"2020","unstructured":"Innao V, Allegra A, Pulvirenti N, Allegra AG, Musolino C. Therapeutic potential of antagomirs in haematological and oncological neoplasms. Eur J Cancer Care. 2020;29(2):e13208.","journal-title":"Eur J Cancer Care"},{"issue":"11","key":"3999_CR234","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/leu.2015.139","volume":"29","author":"AM Dorrance","year":"2015","unstructured":"Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS, et al. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia. Leukemia. 2015;29(11):2143\u201353.","journal-title":"Leukemia"},{"issue":"3","key":"3999_CR235","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.bbrc.2014.10.107","volume":"454","author":"W-Z Wang","year":"2014","unstructured":"Wang W-Z, Lin X-H, Pu Q-H, Liu M-Y, Li L, Wu L-R, et al. Targeting miR-21 sensitizes Ph\u2009+\u2009ALL sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN. Biochem Biophys Res Commun. 2014;454(3):423\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3999_CR236","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1038\/s41467-021-26420-7","volume":"12","author":"L Zhang","year":"2021","unstructured":"Zhang L, Nguyen LXT, Chen Y-C, Wu D, Cook GJ, Hoang DH, et al. Targeting miR-126 in Inv (16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance. Nat Commun. 2021;12(1):6154.","journal-title":"Nat Commun"},{"issue":"1","key":"3999_CR237","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1172\/JCI66005","volume":"124","author":"CS Velu","year":"2014","unstructured":"Velu CS, Chaubey A, Phelan JD, Horman SR, Wunderlich M, Guzman ML, et al. Therapeutic antagonists of MicroRNAs deplete leukemia-initiating cell activity. J Clin Invest. 2014;124(1):222\u201336.","journal-title":"J Clin Invest"},{"issue":"4","key":"3999_CR238","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","volume":"27","author":"E Anastasiadou","year":"2021","unstructured":"Anastasiadou E, Seto AG, Beatty X, Hermreck M, Gilles M-E, Stroopinsky D, et al. Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo. Clin Cancer Res. 2021;27(4):1139\u201349.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3999_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/srep36625","volume":"6","author":"T Barta","year":"2016","unstructured":"Barta T, Peskova L, Hampl A. Mirnasong: a web-based tool for generation and testing of Mirna sponge constructs in silico. Sci Rep. 2016;6(1):36625.","journal-title":"Sci Rep"},{"issue":"11","key":"3999_CR240","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2217\/epi-2019-0352","volume":"12","author":"F Han","year":"2020","unstructured":"Han F, Zhong C, Li W, Wang R, Zhang C, Yang X, et al. Hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p\/CREBRF axis. Epigenomics. 2020;12(11):935\u201353.","journal-title":"Epigenomics"},{"issue":"3","key":"3999_CR241","first-page":"230","volume":"42","author":"Z Wu","year":"2021","unstructured":"Wu Z, Sun Q, Gu D, Wang L, Li J, Jin H. Expression of circ-KEL in acute myeloid leukemia and its regulatory mechanisms in leukemic cells. Zhonghua Xue Ye Xue Za zhi = Zhonghua Xueyexue Zazhi. 2021;42(3):230\u20137.","journal-title":"Zhonghua Xue Ye Xue Za zhi = Zhonghua Xueyexue Zazhi"},{"key":"3999_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117255","volume":"243","author":"H-x Cao","year":"2020","unstructured":"Cao H-x, Miao C-f, Sang L-n, Huang Y-m, Zhang R, Sun L, et al. Circ_0009910 promotes Imatinib resistance through ULK1-induced autophagy by sponging miR-34a-5p in chronic myeloid leukemia. Life Sci. 2020;243:117255.","journal-title":"Life Sci"},{"issue":"3","key":"3999_CR243","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/hon.2874","volume":"39","author":"D Wang","year":"2021","unstructured":"Wang D, Ming X, Xu J, Xiao Y. Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR-5195\u20103p\/GRB10 axis. Hematol Oncol. 2021;39(3):390\u2013400.","journal-title":"Hematol Oncol"},{"key":"3999_CR244","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S259393","author":"F Chen","year":"2020","unstructured":"Chen F, Wang X, Fu S, Wang S, Fu Y, Liu Z, et al. Effect of the up-regulation of circular RNA Hsa_circ_0069767 derived from C-KIT on the biological behavior of multiple myeloma cells. Cancer Manag Res. 2020;12:11321\u201331. https:\/\/doi.org\/10.2147\/CMAR.S259393","journal-title":"Cancer Manag Res"},{"key":"3999_CR245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2162-3619-3-17","volume":"3","author":"L Xu","year":"2014","unstructured":"Xu L, Xu Y, Jing Z, Wang X, Zha X, Zeng C, et al. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Exp Hematol Oncol. 2014;3:1\u20137.","journal-title":"Exp Hematol Oncol"},{"key":"3999_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2019.101436","volume":"47","author":"Y Li","year":"2019","unstructured":"Li Y, Mao M, Liu H, Wang X, Kou Z, Nie Y, et al. MiR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations. Mol Cell Probes. 2019;47:101436.","journal-title":"Mol Cell Probes"},{"issue":"26","key":"3999_CR247","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1182\/blood-2009-03-211938","volume":"114","author":"R Garzon","year":"2009","unstructured":"Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, et al. Microrna 29b functions in acute myeloid leukemia. Blood. 2009;114(26):5331\u201341.","journal-title":"Blood"},{"issue":"25","key":"3999_CR248","doi-asserted-by":"publisher","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","volume":"113","author":"R Garzon","year":"2009","unstructured":"Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, et al. Microrna-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood. 2009;113(25):6411\u20138.","journal-title":"Blood"},{"issue":"37","key":"3999_CR249","doi-asserted-by":"publisher","first-page":"60074","DOI":"10.18632\/oncotarget.11054","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao L, Li Y, Song X, Zhou H, Li N, Miao Y, et al. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. Oncotarget. 2016;7(37):60074.","journal-title":"Oncotarget"},{"issue":"9","key":"3999_CR250","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1158\/1078-0432.CCR-12-3191","volume":"19","author":"X Huang","year":"2013","unstructured":"Huang X, Schwind S, Yu B, Santhanam R, Wang H, Hoellerbauer P, et al. Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clin Cancer Res. 2013;19(9):2355\u201367.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3999_CR251","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrc3690","volume":"14","author":"TL Nero","year":"2014","unstructured":"Nero TL, Morton CJ, Holien JK, Wielens J, Parker MW. Oncogenic protein interfaces: small molecules, big challenges. Nat Rev Cancer. 2014;14(4):248\u201362.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3999_CR252","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","volume":"16","author":"A Beck","year":"2017","unstructured":"Beck A, Goetsch L, Dumontet C, Corva\u00efa N. Strategies and challenges for the next generation of antibody\u2013drug conjugates. Nat Rev Drug Discov. 2017;16(5):315\u201337.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"3999_CR253","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001084","volume":"3","author":"R Noveck","year":"2014","unstructured":"Noveck R, Stroes ES, Flaim JD, Baker BF, Hughes S, Graham MJ, et al. Effects of an antisense oligonucleotide inhibitor of C-reactive protein synthesis on the endotoxin challenge response in healthy human male volunteers. J Am Heart Assoc. 2014;3(4):e001084.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3999_CR254","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.270959.115","volume":"30","author":"G Arun","year":"2016","unstructured":"Arun G, Diermeier S, Akerman M, Chang K-C, Wilkinson JE, Hearn S, et al. Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss. Genes Dev. 2016;30(1):34\u201351.","journal-title":"Genes Dev"},{"issue":"7539","key":"3999_CR255","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature13975","volume":"518","author":"L Meng","year":"2015","unstructured":"Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature. 2015;518(7539):409\u201312.","journal-title":"Nature"},{"key":"3999_CR256","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s12094-020-02377-9","volume":"22","author":"J Chen","year":"2020","unstructured":"Chen J, Lei P, Zhou M. hsa_circ_0121582 inhibits leukemia growth by dampening Wnt\/\u03b2-catenin signaling. Clin Transl Oncol. 2020;22:2293\u2013302.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"3999_CR257","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2018.06.045","volume":"503","author":"L Xia","year":"2018","unstructured":"Xia L, Wu L, Bao J, Li Q, Chen X, Xia H, Xia R. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607\/FZD3\/Wnt\/\u03b2-catenin pathway. Biochem Biophys Res Commun. 2018;503(1):385\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"3999_CR258","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/1535370220918191","volume":"245","author":"F Chen","year":"2020","unstructured":"Chen F, Wang X, Fu S, Wang S, Fu Y, Zhang J, et al. Circular RNA circ-CDYL sponges miR-1180 to elevate yes-associated protein in multiple myeloma. Exp Biol Med. 2020;245(11):925\u201332.","journal-title":"Exp Biol Med"},{"key":"3999_CR259","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.exphem.2018.10.011","volume":"70","author":"J Shang","year":"2019","unstructured":"Shang J, Chen W-M, Wang Z-H, Wei T-N, Chen Z-Z, Wu W-B. CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p\/miR-183-5p\u2013XIAP axis. Exp Hematol. 2019;70:42\u201354. e3.","journal-title":"Exp Hematol"},{"issue":"3","key":"3999_CR260","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1198","volume":"43","author":"T-T Ho","year":"2015","unstructured":"Ho T-T, Zhou N, Huang J, Koirala P, Xu M, Fung R, et al. Targeting non-coding RNAs with the CRISPR\/Cas9 system in human cell lines. Nucleic Acids Res. 2015;43(3):e17\u2013e17.","journal-title":"Nucleic Acids Res"},{"key":"3999_CR261","first-page":"452","volume":"17","author":"O Rossbach","year":"2019","unstructured":"Rossbach O. Artificial circular RNA sponges targeting microRNAs as a novel tool in molecular biology. Mol Ther. 2019;17:452\u20134.","journal-title":"Mol Ther"},{"key":"3999_CR262","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S248822","author":"Z Yi","year":"2020","unstructured":"Yi Z, Li Y, Wu Y, Zeng B, Li H, Ren G, et al. Circular RNA 0001073 attenuates malignant biological behaviours in breast cancer cell and is delivered by nanoparticles to inhibit mice tumour growth. OncoTargets Ther. 2020;13:6157\u201369. https:\/\/doi.org\/10.2147\/OTT.S248822","journal-title":"OncoTargets Ther"},{"key":"3999_CR263","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.canlet.2020.01.022","volume":"475","author":"W Chen","year":"2020","unstructured":"Chen W, Quan Y, Fan S, Wang H, Liang J, Huang L, et al. Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression. Cancer Lett. 2020;475:119\u201328.","journal-title":"Cancer Lett"},{"issue":"1","key":"3999_CR264","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ncrna.2020.02.001","volume":"5","author":"A Buhagiar","year":"2020","unstructured":"Buhagiar A, Borg J, Ayers D. Overview of current microRNA biomarker signatures as potential diagnostic tools for leukaemic conditions. Non-coding RNA Res. 2020;5(1):22\u20136.","journal-title":"Non-coding RNA Res"},{"issue":"5","key":"3999_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2021.100726","volume":"45","author":"M Moloudizargari","year":"2021","unstructured":"Moloudizargari M, Hekmatirad S, Mofarahe ZS, Asghari MH. Exosomal microrna panels as biomarkers for hematological malignancies. Curr Probl Cancer. 2021;45(5):100726.","journal-title":"Curr Probl Cancer"},{"key":"3999_CR266","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00036","volume":"4","author":"NP Hessvik","year":"2013","unstructured":"Hessvik NP, Sandvig K, Llorente A. Exosomal miRNAs as biomarkers for prostate cancer. Front Genet. 2013;4:36.","journal-title":"Front Genet"},{"key":"3999_CR267","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.887518","volume":"12","author":"H Wang","year":"2022","unstructured":"Wang H, You Y, Zhu X. The role of exosomes in the progression and therapeutic resistance of hematological malignancies. Front Oncol. 2022;12:887518.","journal-title":"Front Oncol"},{"issue":"3","key":"3999_CR268","doi-asserted-by":"publisher","first-page":"789","DOI":"10.7150\/thno.18133","volume":"7","author":"P Li","year":"2017","unstructured":"Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7(3):789.","journal-title":"Theranostics"},{"issue":"5","key":"3999_CR269","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3324\/haematol.2010.026138","volume":"96","author":"D Schotte","year":"2011","unstructured":"Schotte D, De Menezes RX, Moqadam FA, Khankahdani LM, Lange-Turenhout E, Chen C, et al. Microrna characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica. 2011;96(5):703.","journal-title":"Haematologica"},{"issue":"1","key":"3999_CR270","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/hon.2567","volume":"37","author":"RS Almeida","year":"2019","unstructured":"Almeida RS, Costa e Silva M, Coutinho LL, Garcia Gomes R, Pedrosa F, Massaro JD, et al. Microrna expression profiles discriminate childhood T-from B\u2010acute lymphoblastic leukemia. Hematol Oncol. 2019;37(1):103\u201312.","journal-title":"Hematol Oncol"},{"key":"3999_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2021.106643","volume":"109","author":"A Zamani","year":"2021","unstructured":"Zamani A, Dolatabadi NF, Houshmand M, Nabavizadeh N. Mir-324-3p and mir-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia. Leuk Res. 2021;109:106643.","journal-title":"Leuk Res"},{"issue":"50","key":"3999_CR272","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.0709313104","volume":"104","author":"S Mi","year":"2007","unstructured":"Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly MB, et al. Microrna expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci U S A. 2007;104(50):19971\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3999_CR273","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-1858-7","volume":"17","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang N, Wang R, Shao T, Feng Y, Yao Y, et al. High expression of miR-363 predicts poor prognosis and guides treatment selection in acute myeloid leukemia. J Transl Med. 2019;17:1\u201310.","journal-title":"J Transl Med"},{"issue":"2","key":"3999_CR274","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/jim-2020-001563","volume":"69","author":"EM Habib","year":"2021","unstructured":"Habib EM, Nosiar NA, Eid MA, Taha AM, Sherief DE, Hassan AE, et al. Circulating miR-146a expression predicts early treatment response to Imatinib in adult chronic myeloid leukemia. J Investig Med. 2021;69(2):333\u20137.","journal-title":"J Investig Med"},{"issue":"1","key":"3999_CR275","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/labmed\/lmab040","volume":"53","author":"EM Habib","year":"2022","unstructured":"Habib EM, Nosiar NA, Eid MA, Taha AM, Sherief DE, Hassan AE, et al. MiR-150 expression in chronic myeloid leukemia: relation to Imatinib response. Lab Med. 2022;53(1):58\u201364.","journal-title":"Lab Med"},{"issue":"11","key":"3999_CR276","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1021\/acsomega.1c00035","volume":"6","author":"A Suchiita","year":"2021","unstructured":"Suchiita A, Guru SA, Yadav P, Masroor M, Samadhiya A, Bhutani N, et al. miR-486-5p: a prognostic biomarker for chronic myeloid leukemia. ACS Omega. 2021;6(11):7711\u20138.","journal-title":"ACS Omega"},{"issue":"10","key":"3999_CR277","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1159\/000518722","volume":"44","author":"MM Ali Beg","year":"2021","unstructured":"Ali Beg MM, Guru SA, Abdullah SM, Ahmad I, Rizvi A, Akhter J, et al. Regulation of miR-126 and miR-122 expression and response of Imatinib treatment on its expression in chronic myeloid leukemia patients. Oncol Res Treat. 2021;44(10):530\u20137.","journal-title":"Oncol Res Treat"},{"issue":"1","key":"3999_CR278","doi-asserted-by":"publisher","first-page":"11295","DOI":"10.1038\/srep11295","volume":"5","author":"NI Hornick","year":"2015","unstructured":"Hornick NI, Huan J, Doron B, Goloviznina NA, Lapidus J, Chang BH, et al. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Rep. 2015;5(1):11295.","journal-title":"Sci Rep"},{"issue":"21","key":"3999_CR279","doi-asserted-by":"publisher","first-page":"30876","DOI":"10.18632\/oncotarget.9021","volume":"7","author":"L Zhang","year":"2016","unstructured":"Zhang L, Pan L, Xiang B, Zhu H, Wu Y, Chen M, et al. Potential role of exosome-associated microrna panels and in vivo environment to predict drug resistance for patients with multiple myeloma. Oncotarget. 2016;7(21):30876.","journal-title":"Oncotarget"},{"issue":"8","key":"3999_CR280","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.biocel.2013.05.030","volume":"45","author":"CH Li","year":"2013","unstructured":"Li CH, Chen Y. Targeting long non-coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45(8):1895\u2013910.","journal-title":"Int J Biochem Cell Biol"},{"key":"3999_CR281","doi-asserted-by":"crossref","unstructured":"Peinado P, Herrera A, Bali\u00f1as C, Mart\u00edn-Padr\u00f3n J, Boyero L, Cuadros M et al. Long noncoding RNAs as cancer biomarkers. Cancer and Noncoding RNAs: Elsevier; 2018. pp. 95\u2013114.","DOI":"10.1016\/B978-0-12-811022-5.00006-1"},{"issue":"1","key":"3999_CR282","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","volume":"44","author":"D Hessels","year":"2003","unstructured":"Hessels D, Gunnewiek JMK, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, et al. DD3PCA3-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol. 2003;44(1):8\u201316.","journal-title":"Eur Urol"},{"issue":"6","key":"3999_CR283","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","volume":"52","author":"J Groskopf","year":"2006","unstructured":"Groskopf J, Aubin SM, Deras IL, Blase A, Bodrug S, Clark C, et al. Aptima PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem. 2006;52(6):1089\u201395.","journal-title":"Clin Chem"},{"issue":"3","key":"3999_CR284","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrurol.2011.10","volume":"8","author":"GL Lee","year":"2011","unstructured":"Lee GL, Dobi A, Srivastava S. Diagnostic performance of the PCA3 urine test. Nat Rev Urol. 2011;8(3):123\u20134.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"3999_CR285","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2217\/epi-2017-0142","volume":"10","author":"J Hu","year":"2018","unstructured":"Hu J, Han Q, Gu Y, Ma J, McGrath M, Qiao F, et al. Circular RNA PVT1 expression and its roles in acute lymphoblastic leukemia. Epigenomics. 2018;10(6):723\u201332.","journal-title":"Epigenomics"},{"issue":"19","key":"3999_CR286","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.1158\/0008-5472.CAN-12-0213","volume":"72","author":"H Nagoshi","year":"2012","unstructured":"Nagoshi H, Taki T, Hanamura I, Nitta M, Otsuki T, Nishida K, et al. Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res. 2012;72(19):4954\u201362.","journal-title":"Cancer Res"},{"issue":"12","key":"3999_CR287","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.3109\/10428194.2013.790543","volume":"54","author":"Y Tsutsumi","year":"2013","unstructured":"Tsutsumi Y, Chinen Y, Sakamoto N, Nagoshi H, Nishida K, Kobayashi S, et al. Deletion or methylation of CDKN2A\/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality. Leuk Lymphoma. 2013;54(12):2760\u20134.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3999_CR288","doi-asserted-by":"publisher","first-page":"14670","DOI":"10.1038\/s41598-019-50864-z","volume":"9","author":"E Gaffo","year":"2019","unstructured":"Gaffo E, Boldrin E, Dal Molin A, Bresolin S, Bonizzato A, Trentin L, et al. Circular RNA differential expression in blood cell populations and exploration of circrna deregulation in pediatric acute lymphoblastic leukemia. Sci Rep. 2019;9(1):14670.","journal-title":"Sci Rep"},{"issue":"10","key":"3999_CR289","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41375-018-0033-0","volume":"32","author":"A L\u2032 Abbate","year":"2018","unstructured":"L\u2032 Abbate A, Tolomeo D, Cifola I, Severgnini M, Turchiano A, Augello B, et al. MYC-containing amplicons in acute myeloid leukemia: genomic structures, evolution, and transcriptional consequences. Leukemia. 2018;32(10):2152\u201366.","journal-title":"Leukemia"},{"key":"3999_CR290","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01655","volume":"10","author":"S Guo","year":"2020","unstructured":"Guo S, Li B, Chen Y, Zou D, Yang S, Zhang Y, et al. Hsa_circ_0012152 and Hsa_circ_0001857 accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Front Oncol. 2020;10:1655.","journal-title":"Front Oncol"},{"key":"3999_CR291","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5967-8","volume":"19","author":"J Zhou","year":"2019","unstructured":"Zhou J, Zhou L-Y, Tang X, Zhang J, Zhai L-L, Yi YY, et al. Circ-Foxo3 is positively associated with the Foxo3 gene and leads to better prognosis of acute myeloid leukemia patients. BMC Cancer. 2019;19:1\u201311.","journal-title":"BMC Cancer"},{"issue":"5","key":"3999_CR292","first-page":"1683","volume":"12","author":"Y Ding","year":"2020","unstructured":"Ding Y, Dong Y, Lu H, Luo X, Fu J, Xiu B, et al. Circular RNA profile of acute myeloid leukaemia indicates circular RNA Annexin A2 as a potential biomarker and therapeutic target for acute myeloid leukaemia. Am J Translational Res. 2020;12(5):1683.","journal-title":"Am J Translational Res"},{"issue":"4","key":"3999_CR293","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1002\/jcp.27145","volume":"234","author":"YY Yi","year":"2019","unstructured":"Yi YY, Yi J, Zhu X, Zhang J, Zhou J, Tang X, et al. Circular RNA of vimentin expression as a valuable predictor for acute myeloid leukemia development and prognosis. J Cell Physiol. 2019;234(4):3711\u20139.","journal-title":"J Cell Physiol"},{"issue":"6","key":"3999_CR294","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41419-018-0699-2","volume":"9","author":"S Li","year":"2018","unstructured":"Li S, Ma Y, Tan Y, Ma X, Zhao M, Chen B, et al. Profiling and functional analysis of circular RNAs in acute promyelocytic leukemia and their dynamic regulation during all-trans retinoic acid treatment. Cell Death Dis. 2018;9(6):651.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3999_CR295","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030597","volume":"18","author":"W Li","year":"2017","unstructured":"Li W, Zhong C, Jiao J, Li P, Cui B, Ji C, et al. Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis. Int J Mol Sci. 2017;18(3):597.","journal-title":"Int J Mol Sci"},{"key":"3999_CR296","doi-asserted-by":"crossref","unstructured":"Fanale D, Taverna S, Russo A, Bazan V. Circular RNA in exosomes. Circular RNAs: biogenesis and functions. 2018:109\u2009\u2013\u200917.","DOI":"10.1007\/978-981-13-1426-1_9"},{"key":"3999_CR297","first-page":"801","volume":"20","author":"Z Wu","year":"2020","unstructured":"Wu Z, Sun H, Wang C, Liu W, Liu M, Zhu Y, et al. Mitochondrial genome-derived circRNA mc-COX2 functions as an oncogene in chronic lymphocytic leukemia. Mol Ther. 2020;20:801\u201311.","journal-title":"Mol Ther"},{"issue":"4","key":"3999_CR298","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4274\/tjh.galenos.2020.2020.0243","volume":"37","author":"Y Luo","year":"2020","unstructured":"Luo Y, Gui R. Circulating exosomal circmyc is associated with recurrence and bortezomib resistance in patients with multiple myeloma. Turk J Hematol. 2020;37(4):248.","journal-title":"Turk J Hematol"},{"key":"3999_CR299","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179490","author":"O Kersy","year":"2021","unstructured":"Kersy O, Salmon-Divon M, Shpilberg O, Hershkovitz-Rokah O. Non-coding RNAs in normal B-cell development and in mantle cell lymphoma: from molecular mechanism to biomarker and therapeutic agent potential. Int J Mol Sci. 2021;22(17):9490. https:\/\/doi.org\/10.3390\/ijms22179490","journal-title":"Int J Mol Sci"},{"issue":"14","key":"3999_CR300","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1111\/jcmm.17795","volume":"27","author":"S Khanmohammadi","year":"2023","unstructured":"Khanmohammadi S, Fallahtafti P. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: a systematic review. J Cell Mol Med. 2023;27(14):1928\u201346.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3999_CR301","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010201","volume":"23","author":"M Fernandes","year":"2021","unstructured":"Fernandes M, Marques H, Teixeira AL, Medeiros R. CeRNA network of lncRNA\/miRNA as Circulating prognostic biomarkers in non-hodgkin lymphomas: bioinformatic analysis and assessment of their prognostic value in an NHL cohort. Int J Mol Sci. 2021;23(1):201.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"3999_CR302","doi-asserted-by":"publisher","first-page":"6024","DOI":"10.1002\/jcb.26800","volume":"119","author":"ES Ghodousi","year":"2018","unstructured":"Ghodousi ES, Rahgozar S. Microrna-326 and microrna\u2010200c: two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia. J Cell Biochem. 2018;119(7):6024\u201332.","journal-title":"J Cell Biochem"},{"issue":"9","key":"3999_CR303","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092658","volume":"15","author":"A Sevcikova","year":"2023","unstructured":"Sevcikova A, Fridrichova I, Nikolaieva N, Kalinkova L, Omelka R, Martiniakova M, et al. Clinical significance of micrornas in hematologic malignancies and hematopoietic stem cell transplantation. Cancers (Basel). 2023;15(9):2658.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3999_CR304","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/cdd.2017.161","volume":"25","author":"JM Adams","year":"2018","unstructured":"Adams JM, Cory S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ. 2018;25(1):27\u201336.","journal-title":"Cell Death Differ"},{"issue":"10","key":"3999_CR305","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","volume":"6","author":"M Konopleva","year":"2016","unstructured":"Konopleva M, Pollyea DA, Potluri J, Chyla B, Hogdal L, Busman T, et al. Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia. Cancer Discov. 2016;6(10):1106\u201317.","journal-title":"Cancer Discov"},{"issue":"22","key":"3999_CR306","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1182\/blood-2017-06-788786","volume":"130","author":"S Kumar","year":"2017","unstructured":"Kumar S, Kaufman JL, Gasparetto C, Mikhael J, Vij R, Pegourie B, et al. Efficacy of venetoclax as targeted therapy for relapsed\/refractory t (11; 14) multiple myeloma. Blood. 2017;130(22):2401\u20139.","journal-title":"Blood"},{"issue":"9","key":"3999_CR307","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/s41375-018-0223-9","volume":"32","author":"C Touzeau","year":"2018","unstructured":"Touzeau C, Maciag P, Amiot M, Moreau P. Targeting Bcl-2 for the treatment of multiple myeloma. Leukemia. 2018;32(9):1899\u2013907.","journal-title":"Leukemia"},{"issue":"1","key":"3999_CR308","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37216-2","volume":"14","author":"A Portelinha","year":"2023","unstructured":"Portelinha A, da Silva Ferreira M, Erazo T, Jiang M, Asgari Z, de Stanchina E, et al. Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. Nat Commun. 2023;14(1):1522.","journal-title":"Nat Commun"},{"issue":"9","key":"3999_CR309","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1182\/blood.2022016466","volume":"141","author":"I Peris","year":"2023","unstructured":"Peris I, Romero-Murillo S, Mart\u00ednez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, et al. Activation of the PP2A-B56\u03b1 heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 2023;141(9):1047\u201359.","journal-title":"Blood"},{"issue":"4","key":"3999_CR310","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/2643-3230.BCD-22-0205","volume":"4","author":"CA Lachowiez","year":"2023","unstructured":"Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, et al. A phase Ib\/II study of Ivosidenib with venetoclax\u2009\u00b1\u2009azacitidine in IDH1-mutated myeloid malignancies. Blood Cancer Discov. 2023;4(4):276\u201393.","journal-title":"Blood Cancer Discov"},{"issue":"11","key":"3999_CR311","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S1470-2045(21)00494-0","volume":"22","author":"CD DiNardo","year":"2021","unstructured":"DiNardo CD, Schuh AC, Stein EM, Montesinos P, Wei AH, de Botton S, et al. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial. Lancet Oncol. 2021;22(11):1597\u2013608.","journal-title":"Lancet Oncol"},{"key":"3999_CR312","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175526","volume":"943","author":"SA Setiawan","year":"2023","unstructured":"Setiawan SA, Liu WZ, Weng PW, Lee C-H, Yadav VK, Hardianti MS, et al. Synergistic disruption of BTK and BCL-2 causes apoptosis while inducing ferroptosis in double-hit lymphoma. Eur J Pharmacol. 2023;943:175526.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3999_CR313","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114557","volume":"15","author":"M Carlet","year":"2023","unstructured":"Carlet M, Schmelz K, Vergalli J, Herold T, Senft D, Jurinovic V, et al. X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed\/refractory ALL. EMBO Mol Med. 2023;15(1):e14557.","journal-title":"EMBO Mol Med"},{"key":"3999_CR314","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1029-8","volume":"18","author":"Y Gong","year":"2019","unstructured":"Gong Y, Fan Z, Luo G, Yang C, Huang Q, Fan K, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18:1\u201317.","journal-title":"Mol Cancer"},{"issue":"5","key":"3999_CR315","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/cdd.2016.8","volume":"23","author":"Z Su","year":"2016","unstructured":"Su Z, Yang Z, Xie L, DeWitt J, Chen Y. Cancer therapy in the necroptosis era. Cell Death Differ. 2016;23(5):748\u201356.","journal-title":"Cell Death Differ"},{"issue":"339","key":"3999_CR316","doi-asserted-by":"publisher","first-page":"ra33969","DOI":"10.1126\/scitranslmed.aad3099","volume":"8","author":"G Brumatti","year":"2016","unstructured":"Brumatti G, Ma C, Lalaoui N, Nguyen N-Y, Navarro M, Tanzer MC, et al. The caspase-8 inhibitor emricasan combines with the SMAC mimetic Birinapant to induce necroptosis and treat acute myeloid leukemia. Sci Transl Med. 2016;8(339):ra33969\u201369.","journal-title":"Sci Transl Med"},{"issue":"14","key":"3999_CR317","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143579","volume":"13","author":"M Berehab","year":"2021","unstructured":"Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, et al. Apoptotic and non-apoptotic modalities of thymoquinone-induced lymphoma cell death: highlight of the role of cytosolic calcium and necroptosis. Cancers (Basel). 2021;13(14):3579.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3999_CR318","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41419-020-2304-8","volume":"11","author":"S Song","year":"2020","unstructured":"Song S, Lee J-Y, Ermolenko L, Mazumder A, Ji S, Ryu H, et al. Tetrahydrobenzimidazole TMQ0153 triggers apoptosis, autophagy and necroptosis crosstalk in chronic myeloid leukemia. Cell Death Dis. 2020;11(2):109.","journal-title":"Cell Death Dis"},{"key":"3999_CR319","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2020.12.015","volume":"500","author":"N Casagrande","year":"2021","unstructured":"Casagrande N, Borghese C, Favero A, Vicenzetto C, Aldinucci D. Trabectedin overcomes doxorubicin-resistance, counteracts tumor-immunosuppressive reprogramming of monocytes and decreases xenograft growth in hodgkin lymphoma. Cancer Lett. 2021;500:182\u201393.","journal-title":"Cancer Lett"},{"issue":"8","key":"3999_CR320","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","volume":"24","author":"DC Johnson","year":"2018","unstructured":"Johnson DC, Taabazuing CY, Okondo MC, Chui AJ, Rao SD, Brown FC, et al. DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia. Nat Med. 2018;24(8):1151\u20136.","journal-title":"Nat Med"},{"issue":"10","key":"3999_CR321","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102952","volume":"12","author":"SM Gaikwad","year":"2020","unstructured":"Gaikwad SM, Phyo Z, Arteaga AQ, Gorjifard S, Calabrese DR, Connors D, et al. A small molecule stabilizer of the MYC G4-quadruplex induces endoplasmic reticulum stress, senescence and pyroptosis in multiple myeloma. Cancers (Basel). 2020;12(10):2952.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3999_CR322","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/15384047.2022.2058862","volume":"23","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Kong Y, Jiang M, Kuang L, Wan J, Liu S, et al. Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines. Cancer Biol Ther. 2022;23(1):328\u201335.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"3999_CR323","first-page":"2817","volume":"12","author":"Y Dai","year":"2022","unstructured":"Dai Y, Huang J, Kuang P, Hu Y, Zeng Q, Zhang W, et al. Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in Philadelphia chromosome positive acute lymphoblastic leukemia. Am J Cancer Res. 2022;12(6):2817.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"3999_CR324","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-019-0230-2","volume":"5","author":"C-S Shi","year":"2019","unstructured":"Shi C-S, Kehrl JH. Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL. Cell Death Discov. 2019;5(1):151.","journal-title":"Cell Death Discov"},{"issue":"4","key":"3999_CR325","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2022.5409","volume":"61","author":"H-Q Dong","year":"2022","unstructured":"Dong H-Q, Liang S-J, Xu Y-L, Dai Y, Sun N, Deng D-H, et al. Liproxstatin\u20131 induces cell cycle arrest, apoptosis, and caspase\u20133\/GSDME\u2013dependent secondary pyroptosis in K562 cells. Int J Oncol. 2022;61(4):1\u201313.","journal-title":"Int J Oncol"},{"issue":"7","key":"3999_CR326","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41401-023-01060-3","volume":"44","author":"J-p Liang","year":"2023","unstructured":"Liang J-p, He Y-m, Cui Y-l, Sun Y-n, He G-s, Zhu Z-g, et al. Proteasomal inhibitors induce myeloma cell pyroptosis via the BAX\/GSDME pathway. Acta Pharmacol Sin. 2023;44(7):1464\u201374.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"3999_CR327","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Berghe TV. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349.","journal-title":"Cancer Cell"},{"issue":"4","key":"3999_CR328","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, Guo P, Xie X, Wang Y, Chen G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2017;21(4):648\u201357.","journal-title":"J Cell Mol Med"},{"key":"3999_CR329","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.014888","author":"JS Rink","year":"2021","unstructured":"Rink JS, Lin AY, McMahon KM, Calvert AE, Yang S, Taxter T, et al. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis. J Biol Chem. 2021. https:\/\/doi.org\/10.1074\/jbc.RA120.014888.","journal-title":"J Biol Chem"},{"key":"3999_CR330","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bcp.2017.06.112","volume":"140","author":"L Probst","year":"2017","unstructured":"Probst L, D\u00e4chert J, Schenk B, Fulda S. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochem Pharmacol. 2017;140:41\u201352.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3999_CR331","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1566523219666190628152137","volume":"19","author":"X Xia","year":"2019","unstructured":"Xia X, Fan X, Zhao M, Zhu P. The relationship between ferroptosis and tumors: a novel landscape for therapeutic approach. Curr Gene Ther. 2019;19(2):117\u201324.","journal-title":"Curr Gene Ther"},{"issue":"6","key":"3999_CR332","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41375-022-01573-6","volume":"36","author":"B Pardieu","year":"2022","unstructured":"Pardieu B, Pasanisi J, Ling F, Dal Bello R, Penneroux J, Su A, et al. Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia. Leukemia. 2022;36(6):1585\u201395.","journal-title":"Leukemia"},{"issue":"3","key":"3999_CR333","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.212308","volume":"105","author":"EM Algar\u00edn","year":"2020","unstructured":"Algar\u00edn EM, D\u00edaz-Tejedor A, Mogoll\u00f3n P, Hern\u00e1ndez-Garc\u00eda S, Corchete LA, San-Segundo L, et al. Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma. Haematologica. 2020;105(3):e116.","journal-title":"Haematologica"},{"issue":"4","key":"3999_CR334","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2022.5409","volume":"61","author":"H-Q Dong","year":"2022","unstructured":"Dong H-Q, Liang S-J, Xu Y-L, Dai Y, Sun N, Deng D-H, et al. Liproxstatin-1 induces cell cycle arrest, apoptosis, and caspase-3\/GSDME-dependent secondary pyroptosis in K562 cells. Int J Oncol. 2022;61(4):119.","journal-title":"Int J Oncol"},{"issue":"10","key":"3999_CR335","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1182\/blood.2020009404","volume":"138","author":"A Schmitt","year":"2021","unstructured":"Schmitt A, Xu W, Bucher P, Grimm M, Konantz M, Horn H, et al. Dimethyl fumarate induces ferroptosis and impairs NF-\u03baB\/STAT3 signaling in DLBCL. Blood. 2021;138(10):871\u201384.","journal-title":"Blood"},{"issue":"1","key":"3999_CR336","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","volume":"29","author":"Z Wang","year":"2021","unstructured":"Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L, et al. A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis. Mol Ther. 2021;29(1):263\u201374.","journal-title":"Mol Ther"},{"issue":"1","key":"3999_CR337","doi-asserted-by":"publisher","first-page":"e1593","DOI":"10.1038\/cddis.2014.525","volume":"6","author":"G Choudhary","year":"2015","unstructured":"Choudhary G, Al-Harbi S, Mazumder S, Hill B, Smith M, Bodo J, et al. MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies. Cell Death Dis. 2015;6(1):e1593\u2013e.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3999_CR338","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","volume":"36","author":"R Gui\u00e8ze","year":"2019","unstructured":"Gui\u00e8ze R, Liu VM, Rosebrock D, Jourdain AA, Hern\u00e1ndez-S\u00e1nchez M, Zurita AM, et al. Mitochondrial reprogramming underlies resistance to BCL-2 Inhibition in lymphoid malignancies. Cancer Cell. 2019;36(4):369\u201384. e13.","journal-title":"Cancer Cell"},{"issue":"Supplement 1","key":"3999_CR339","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood-2022-158694","volume":"140","author":"O Dufva","year":"2022","unstructured":"Dufva O, Kuusanm\u00e4ki H, Vaha-Koskela M, Lepp\u00e4 A-M, Huuhtanen J, V\u00e4nttinen I, et al. Erythroid\/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia. Blood. 2022;140(Supplement 1):101\u20133.","journal-title":"Blood"},{"issue":"5","key":"3999_CR340","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3324\/haematol.2022.282031","volume":"108","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yan F, Jiang VC, Li Y, Che Y, McIntosh J, et al. Pirtobrutinib and venetoclax combination overcomes resistance to targeted and chimeric antigen receptor T-cell therapy in aggressive mantle cell lymphoma. Haematologica. 2022;108(5):1412.","journal-title":"Haematologica"},{"issue":"1","key":"3999_CR341","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1078-0432.CCR-22-0978","volume":"29","author":"Y Zhai","year":"2023","unstructured":"Zhai Y, Tang Q, Fang DD, Deng J, Zhang K, Wang Q, et al. Lisaftoclax in combination with Alrizomadlin overcomes venetoclax resistance in acute myeloid leukemia and acute lymphoblastic leukemia: preclinical studies. Clin Cancer Res. 2023;29(1):183\u201396.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3999_CR342","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41375-022-01627-9","volume":"36","author":"YJ Thus","year":"2022","unstructured":"Thus YJ, Eldering E, Kater AP, Spaargaren M. Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma. Leukemia. 2022;36(9):2165\u201376.","journal-title":"Leukemia"},{"issue":"24","key":"3999_CR343","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1182\/blood.2021014241","volume":"140","author":"M Janssen","year":"2022","unstructured":"Janssen M, Schmidt C, Bruch P-M, Blank MF, Rohde C, Waclawiczek A, et al. Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1. Blood. 2022;140(24):2594\u2013610.","journal-title":"Blood"},{"issue":"35","key":"3999_CR344","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1200\/JCO.22.00602","volume":"40","author":"N Daver","year":"2022","unstructured":"Daver N, Perl AE, Maly J, Levis M, Ritchie E, Litzow M, et al. Venetoclax plus gilteritinib for FLT3-mutated relapsed\/refractory acute myeloid leukemia. J Clin Oncol. 2022;40(35):4048\u201359.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3999_CR345","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1182\/blood.2021013156","volume":"139","author":"CP Mill","year":"2022","unstructured":"Mill CP, Fiskus W, DiNardo CD, Birdwell C, Davis JA, Kadia TM, et al. Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. Blood. 2022;139(6):907\u201321.","journal-title":"Blood"},{"issue":"1","key":"3999_CR346","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2371807","volume":"2022","author":"F Li","year":"2022","unstructured":"Li F, Xia Q, Ren L, Nie Y, Ren H, Guo X, et al. GSDME increases chemotherapeutic drug sensitivity by inducing pyroptosis in retinoblastoma cells. Oxid Med Cell Longev. 2022;2022(1):2371807.","journal-title":"Oxid Med Cell Longev"},{"key":"3999_CR347","doi-asserted-by":"publisher","DOI":"10.1002\/bmm2.12079","author":"L Zhou","year":"2024","unstructured":"Zhou L, Chen Y, Xie D, Li K, Cui X, Dietrich CF, et al. Regulated cell death-amplified sonodynamic anti\u2010tumor immune nanotherapeutics. BMEMat. 2024. https:\/\/doi.org\/10.1002\/bmm2.12079.","journal-title":"BMEMat"},{"key":"3999_CR348","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202310342","author":"Y Su","year":"2024","unstructured":"Su Y, Liu B, Wang B, Chan L, Xiong C, Lu L, et al. Progress and challenges in tumor ferroptosis treatment strategies: a comprehensive review of metal complexes and nanomedicine. Small. 2024;20(25):2310342. https:\/\/doi.org\/10.1002\/smll.202310342","journal-title":"Small"},{"issue":"15","key":"3999_CR349","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1002\/ange.202010281","volume":"133","author":"D Wu","year":"2021","unstructured":"Wu D, Wang S, Yu G, Chen X. Cell death mediated by the pyroptosis pathway with the aid of nanotechnology: prospects for cancer therapy. Angew Chem. 2021;133(15):8096\u2013112.","journal-title":"Angew Chem"},{"key":"3999_CR350","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jconrel.2022.06.060","volume":"349","author":"X Zang","year":"2022","unstructured":"Zang X, Song J, Li Y, Han Y. Targeting necroptosis as an alternative strategy in tumor treatment: from drugs to nanoparticles. J Controlled Release. 2022;349:213\u201326.","journal-title":"J Controlled Release"},{"issue":"7","key":"3999_CR351","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1007\/s10495-023-01851-3","volume":"28","author":"J Li","year":"2023","unstructured":"Li J, Yi X, Liu L, Wang X, Ai J. Advances in tumor nanotechnology: theragnostic implications in tumors via targeting regulated cell death. Apoptosis. 2023;28(7):1198\u2013215.","journal-title":"Apoptosis"},{"issue":"2","key":"3999_CR352","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7150\/thno.67932","volume":"12","author":"Q Zeng","year":"2022","unstructured":"Zeng Q, Ma X, Song Y, Chen Q, Jiao Q, Zhou L. Targeting regulated cell death in tumor nanomedicines. Theranostics. 2022;12(2):817.","journal-title":"Theranostics"},{"issue":"1","key":"3999_CR353","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mco2.8","volume":"1","author":"L Cai","year":"2020","unstructured":"Cai L, Xu J, Yang Z, Tong R, Dong Z, Wang C, Leong KW. Engineered biomaterials for cancer immunotherapy. MedComm. 2020;1(1):35\u201346.","journal-title":"MedComm"},{"key":"3999_CR354","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.biomaterials.2016.06.032","volume":"102","author":"X Zhao","year":"2016","unstructured":"Zhao X, Yang K, Zhao R, Ji T, Wang X, Yang X, et al. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy. Biomaterials. 2016;102:187\u201397.","journal-title":"Biomaterials"},{"issue":"3","key":"3999_CR355","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306580","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Guo Y, Zhang K, Zhu R, Chen X, Zhang Z, et al. Cell death pathway regulation by functional nanomedicines for robust antitumor immunity. Adv Sci. 2024;11(3):2306580.","journal-title":"Adv Sci"},{"key":"3999_CR356","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jare.2023.09.018","volume":"62","author":"J Lu","year":"2024","unstructured":"Lu J, Tai Z, Wu J, Li L, Zhang T, Liu J, et al. Nanomedicine-induced programmed cell death enhances tumor immunotherapy. J Adv Res. 2024;62:199\u2013217.","journal-title":"J Adv Res"},{"issue":"10","key":"3999_CR357","first-page":"1933","volume":"8","author":"S Wang","year":"2018","unstructured":"Wang S, Luo J, Zhang Z, Dong D, Shen Y, Fang Y, et al. Iron and magnetic: new research direction of the ferroptosis-based cancer therapy. Am J Cancer Res. 2018;8(10):1933.","journal-title":"Am J Cancer Res"},{"key":"3999_CR358","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-019-1397-3","volume":"38","author":"F Wang","year":"2019","unstructured":"Wang F, Lv H, Zhao B, Zhou L, Wang S, Luo J, et al. Iron and leukemia: new insights for future treatments. J Exp Clin Cancer Res. 2019;38:1\u201317.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"3999_CR359","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201704007","volume":"30","author":"Z Shen","year":"2018","unstructured":"Shen Z, Song J, Yung BC, Zhou Z, Wu A, Chen X. Emerging strategies of cancer therapy based on ferroptosis. Adv Mater. 2018;30(12):1704007.","journal-title":"Adv Mater"},{"issue":"2","key":"3999_CR360","first-page":"498","volume":"13","author":"Q-T Huang","year":"2023","unstructured":"Huang Q-T, Hu Q-Q, Wen Z-F, Li Y-L. Iron oxide nanoparticles inhibit tumor growth by ferroptosis in diffuse large B-cell lymphoma. Am J Cancer Res. 2023;13(2):498.","journal-title":"Am J Cancer Res"},{"key":"3999_CR361","doi-asserted-by":"crossref","unstructured":"Namvar F, Rahman HS, Mohamad R, Baharara J, Mahdavi M, Amini E et al. Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract. Int J Nanomed. 2014;9:2479\u201388.","DOI":"10.2147\/IJN.S59661"},{"key":"3999_CR362","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S355408","author":"SA Alsagaby","year":"2022","unstructured":"Alsagaby SA. Transcriptomics-based investigation of molecular mechanisms underlying apoptosis induced by ZnO nanoparticles in human diffuse large B-cell lymphoma. Int J Nanomedicine. 2022;17:2261\u201381. https:\/\/doi.org\/10.2147\/IJN.S355408","journal-title":"Int J Nanomedicine"},{"key":"3999_CR363","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123971","volume":"654","author":"T Yang","year":"2024","unstructured":"Yang T, Gou H, Lin T, Yang Y, Jin X, Dong T, et al. Fisetin nanoparticles based on cells cycle and apoptosis intervention for the treatment of lymphoma and leukemia. Int J Pharm. 2024;654:123971.","journal-title":"Int J Pharm"},{"issue":"5","key":"3999_CR364","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, et al. Imidazole ketone Erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biology. 2019;26(5):623\u201333. e9.","journal-title":"Cell Chem Biology"},{"issue":"1","key":"3999_CR365","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.1038\/s41598-020-64828-1","volume":"10","author":"W Guo","year":"2020","unstructured":"Guo W, Song Y, Song W, Liu Y, Liu Z, Zhang D, et al. Co-delivery of doxorubicin and curcumin with polypeptide nanocarrier for synergistic lymphoma therapy. Sci Rep. 2020;10(1):7832.","journal-title":"Sci Rep"},{"key":"3999_CR366","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S205456","author":"X Dai","year":"2019","unstructured":"Dai X, Yao J, Zhong Y, Li Y, Lu Q, Zhang Y, et al. Preparation and characterization of Fe3O4@ MTX magnetic nanoparticles for thermochemotherapy of primary central nervous system lymphoma in vitro and in vivo. Int J Nanomedicine. 2019;14:9647\u201363. https:\/\/doi.org\/10.2147\/IJN.S205456","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3999_CR367","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/10717544.2021.1898703","volume":"28","author":"M Song","year":"2021","unstructured":"Song M, Xia W, Tao Z, Zhu B, Zhang W, Liu C, et al. Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy. Drug Deliv. 2021;28(1):594\u2013606.","journal-title":"Drug Deliv"},{"issue":"2","key":"3999_CR368","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202305361","volume":"36","author":"L Zhou","year":"2024","unstructured":"Zhou L, Lyu J, Liu F, Su Y, Feng L, Zhang X. Immunogenic PANoptosis-initiated cancer sono\u2010immune reediting nanotherapy by iteratively boosting cancer immunity cycle. Adv Mater. 2024;36(2):2305361.","journal-title":"Adv Mater"},{"key":"3999_CR369","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123241","volume":"643","author":"F Zhang","year":"2023","unstructured":"Zhang F, Yang Q, Tang S, Jiang S, Zhao Q, Li J, et al. CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma. Int J Pharm. 2023;643:123241.","journal-title":"Int J Pharm"},{"issue":"1","key":"3999_CR370","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41408-023-00955-y","volume":"13","author":"D Dutta","year":"2023","unstructured":"Dutta D, Liu J, Wen K, Kurata K, Fulciniti M, Gulla A, et al. BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma. Blood Cancer J. 2023;13(1):184.","journal-title":"Blood Cancer J"},{"key":"3999_CR371","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.actbio.2022.03.035","volume":"144","author":"W Zhong","year":"2022","unstructured":"Zhong W, Zhang X, Duan X, Liu H, Fang Y, Luo M, et al. Redox-responsive self-assembled polymeric nanoprodrug for delivery of gemcitabine in B-cell lymphoma therapy. Acta Biomater. 2022;144:67\u201380.","journal-title":"Acta Biomater"},{"key":"3999_CR372","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2021.08.035","volume":"338","author":"S Wang","year":"2021","unstructured":"Wang S, Liu X, Wang S, Ouyang L, Li H, Ding J, et al. Imatinib co-loaded targeted Realgar nanocrystal for synergistic therapy of chronic myeloid leukemia. J Control Release. 2021;338:190\u2013200.","journal-title":"J Control Release"},{"issue":"1","key":"3999_CR373","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22672-5","volume":"12","author":"D Cholujova","year":"2022","unstructured":"Cholujova D, Koklesova L, Lukacova Bujnakova Z, Dutkova E, Valuskova Z, Beblava P, et al. In vitro and ex vivo anti-myeloma effects of nanocomposite As4S4\/ZnS\/Fe3O4. Sci Rep. 2022;12(1):17961.","journal-title":"Sci Rep"},{"issue":"11","key":"3999_CR374","doi-asserted-by":"publisher","first-page":"17689","DOI":"10.1021\/acsnano.1c05547","volume":"15","author":"Y Du","year":"2021","unstructured":"Du Y, Han M, Cao K, Li Q, Pang J, Dou L, et al. Gold nanorods exhibit intrinsic therapeutic activity via controlling N 6-methyladenosine-based epitranscriptomics in acute myeloid leukemia. ACS Nano. 2021;15(11):17689\u2013704.","journal-title":"ACS Nano"},{"key":"3999_CR375","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-00922-4","volume":"19","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, Jiang D, Sun X, Mo Q, Chen S, Chen W, et al. Biomimetic nanotherapy: core\u2013shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma. J Nanobiotechnol. 2021;19:1\u201319.","journal-title":"J Nanobiotechnol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03999-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03999-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T16:07:43Z","timestamp":1760458063000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03999-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":375,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3999"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03999-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"350"}}